<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Probiotics for preventing acute upper respiratory tract infections - Zhao, Y - 2022 | Cochrane Library</title> <meta content="Probiotics for preventing acute upper respiratory tract infections - Zhao, Y - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006895.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Probiotics for preventing acute upper respiratory tract infections - Zhao, Y - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006895.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006895.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Probiotics for preventing acute upper respiratory tract infections" name="citation_title"/> <meta content="Yunli Zhao" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="yunlizhao948@outlook.com" name="citation_author_email"/> <meta content="Bi Rong Dong" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Qiukui Hao" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD006895.pub4" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/08/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006895.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006895.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006895.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Bacterial Agents [therapeutic use]; *Influenza Vaccines; *Influenza, Human; *Probiotics [therapeutic use]; Randomized Controlled Trials as Topic; *Respiratory Tract Infections [drug therapy, prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006895.pub4&amp;doi=10.1002/14651858.CD006895.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="p32VIvbS";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006895\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006895\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","pt","ko","ms","ja","hr","fa","fr","hu"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006895.pub4",title:"Probiotics for preventing acute upper respiratory tract infections",firstPublishedDate:"Aug 24, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006895.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006895.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006895.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006895.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006895.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006895.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006895.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006895.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006895.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006895.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14747 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006895.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-sec-0123"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-sec-0051"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-sec-0110"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/appendices#CD006895-sec-0128"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/supinfo/CD006895StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/supinfo/CD006895StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Probiotics for preventing acute upper respiratory tract infections</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information#CD006895-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Yunli Zhao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information#CD006895-cr-0005">Bi Rong Dong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information#CD006895-cr-0006">Qiukui Hao</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information/en#CD006895-sec-0137">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 August 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006895.pub4">https://doi.org/10.1002/14651858.CD006895.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006895-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006895-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006895-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006895-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006895-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD006895-abs-0006">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006895-abs-0001" lang="en"> <section id="CD006895-sec-0001"> <h3 class="title" id="CD006895-sec-0001">Background</h3> <p>Probiotics are live micro‐organisms that may give a beneficial physiological effect when administered in adequate amounts. Some trials show that probiotic strains can prevent respiratory infections. Even though our previously published review showed the benefits of probiotics for acute upper respiratory tract infections (URTIs), several new studies have been published. This is an update of a review first published in 2011 and updated in 2015. </p> </section> <section id="CD006895-sec-0002"> <h3 class="title" id="CD006895-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of probiotics (any specified strain or dose), compared with placebo or no treatment, in the prevention of acute URTIs in people of all ages, at risk of acute URTIs. </p> </section> <section id="CD006895-sec-0003"> <h3 class="title" id="CD006895-sec-0003">Search methods</h3> <p>We searched CENTRAL (2022, Issue 6), MEDLINE (1950 to May week 2, 2022), Embase (1974 to 10 May 2022), Web of Science (1900 to 10 May 2022), the Chinese Biomedical Literature Database, which includes the China Biological Medicine Database (from 1978 to 10 May 2022), the Chinese Medicine Popular Science Literature Database (from 2000 to 10 May 2022), and the Master's Degree Dissertation of Beijing Union Medical College Database (from 1981 to 10 May 2022). We searched the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov for completed and ongoing trials on 10 May 2022. </p> </section> <section id="CD006895-sec-0004"> <h3 class="title" id="CD006895-sec-0004">Selection criteria</h3> <p>We included individual randomised controlled trials (RCTs) and cluster‐RCTs comparing probiotics with placebo or no treatment to prevent acute URTIs. The participants were children, adults, or the elderly in the community, care facilities, schools, or hospitals. Our main outcomes were the number of participants diagnosed with URTIs (at least one event and at least three events), the incidence rate (number of cases/person year) of acute URTIs, and the mean duration of an episode of URTIs. Our secondary outcomes were the number of participants who were absent from childcare centre, school, or work due to acute URTIs; the number of participants who used prescribed antibiotics for acute URTIs; and the number of participants who experienced at least one adverse event from probiotics. We excluded studies if they did not specify acute respiratory infections as 'upper'; studies with more than 50% of participants vaccinated against influenza or other acute URTIs within the last 12 months; and studies with significantly different proportions of vaccinated participants between the probiotics arm and the placebo or no treatment arm. </p> </section> <section id="CD006895-sec-0005"> <h3 class="title" id="CD006895-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the eligibility of trials and extracted data using standard Cochrane methodological procedures. We analysed both intention‐to‐treat and per‐protocol data and used a random‐effects model. We expressed results as risk ratios (RRs) for dichotomous outcomes and mean differences (MDs) for continuous outcomes, both with 95% confidence intervals (CIs). We assessed the certainty of the evidence using the GRADE approach. </p> </section> <section id="CD006895-sec-0006"> <h3 class="title" id="CD006895-sec-0006">Main results</h3> <p>We included 23 individual RCTs and one cluster‐RCT. As one of the individual RCTs did not report outcomes in a usable way, we could only meta‐analyse data from 23 trials, involving a total of 6950 participants including children (aged from one month to 11 years old), adults (mean age 37.3), and older people (mean age 84.6 years). One trial reported 22.5% flu‐vaccine participants within the last 12 months, and 25.4% flu‐vaccine participants during the intervention. Probiotics were more likely to be given with milk‐based food in children; administered in powder form in adults; and given with milk‐based food or in capsules in the elderly. Most of the studies used one or two strains (e.g. <i>Lactobacillus plantarum</i> HEAL9, <i>Lactobacillus paracasei</i> (8700:2 or N1115)) and 10<sup>9</sup> or 10<sup>11</sup> colony‐forming units (CFU)/day of probiotics for more than three months. </p> <p>We found that probiotics may reduce the number of participants diagnosed with URTIs (at least one event) (RR 0.76, 95% CI 0.67 to 0.87; P &lt; 0.001; 16 studies, 4798 participants; low‐certainty evidence); likely reduce the number of participants diagnosed with URTIs (at least three events) (RR 0.59, 95% CI 0.38 to 0.91; P = 0.02; 4 studies, 763 participants; moderate‐certainty evidence); may reduce the incidence rate (number of cases/person year) of URTIs (rate ratio 0.82, 95% CI 0.73 to 0.92, P = 0.001; 12 studies, 4364 participants; low‐certainty evidence); may reduce the mean duration of an episode of acute URTIs (MD −1.22 days, 95% CI −2.12 to −0.33; P = 0.007; 6 studies, 2406 participants; low‐certainty evidence); likely reduce the number of participants who used prescribed antibiotics for acute URTIs (RR 0.58, 95% CI 0.42 to 0.81; P = 0.001; 6 studies, 1548 participants; moderate‐certainty evidence); and may not increase the number of participants who experienced at least one adverse event (RR 1.02, 95% CI 0.90 to 1.15; P = 0.79; 8 studies, 2456 participants; low‐certainty evidence). Evidence showing a decrease in the number of people absent from childcare centre, school, or work due to acute URTIs with probiotics is very uncertain (RR 0.14, 95% CI 0.03 to 0.59; 1 study, 80 participants; very low‐certainty evidence). Adverse events from probiotics were minor, and most commonly gastrointestinal symptoms, such as vomiting, flatulence, diarrhoea, and bowel pain.  </p> </section> <section id="CD006895-sec-0007"> <h3 class="title" id="CD006895-sec-0007">Authors' conclusions</h3> <p>Overall, we found that probiotics were better than placebo or no treatment in preventing acute URTIs. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006895-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006895-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006895-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006895-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006895-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006895-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006895-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/hu#CD006895-abs-0015">Magyar</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006895-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD006895-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006895-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD006895-abs-0005">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006895-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006895-abs-0002" lang="en"> <h3>Can probiotics (live micro‐organisms) prevent upper respiratory tract infections such as the common cold? </h3> <p><b>Key messages</b> </p> <p>Probiotics may be beneficial in preventing at least one occurrence of acute upper respiratory tract infection (URTI), and are likely beneficial in preventing at least three occurrences of URTIs. More studies conducted in the elderly are needed. Larger, well‐designed studies are needed to give better estimates of the benefits and potential harms of probiotics use. </p> <p><b>What are acute upper respiratory tract infections?</b> </p> <p>Acute URTIs include colds, influenza, and infections of the throat, nose, or sinuses. Symptoms include fever, cough, pain and headaches. Most acute URTIs are caused by viruses, and usually get better within three to seven days.  </p> <p><b>What are probiotics?</b> </p> <p>A common description of probiotics is live micro‐organisms that give a beneficial effect to the body when consumed in adequate amounts. Lactic acid bacteria and bifidobacteria are the most common types and are commonly consumed in fermented foods, such as yoghurt and soy yoghurt, or as dietary supplements. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out if probiotics prevent acute URTIs in people of all ages with a healthy immune system. </p> <p><b>What did we do?</b> </p> <p>We searched for studies that investigated probiotics for URTIs. We compared and summarised the results of the studies, and rated our confidence in the evidence, based on factors such as study methods and sizes. </p> <p><b>What did we find?</b> </p> <p>We found 24 studies. We analysed data from 6950 people, including children (aged from 1 month to 11 years old), adults (mean age 37.3 years), and older people (mean age 84.6 years) from Italy, Japan, the United States, Croatia, England, Finland, Sweden, Chile, China, Denmark, Germany, Thailand, and Turkey. It was not clear in which countries two trials were conducted. Most of the studies were conducted in the community, care facilities, schools, and hospitals for three months during the winter/spring. Probiotics were more likely to be given with milk‐based food in children, in powder form in adults, and with milk‐based food or capsules in the elderly. One or two strains (e.g. <i>Lactobacillus plantarum</i> HEAL9, <i>Lactobacillus paracasei</i> (8700:2 or N1115)) and 10<sup>9</sup> or 10<sup>11</sup> colony‐forming units (CFU)/day of probiotics were used in most of the studies.  </p> <p><b>Main results</b> </p> <p>Probiotics may reduce the number of people diagnosed with at least one URTI by about 24%; likely reduce the number of people diagnosed with at least three URTIs by about 41%; may reduce the incidence rate (number of new cases during a specified period of time) of acute URTIs by about 18%; may reduce the mean duration of an episode of acute URTIs by about 1.22 days; likely reduce the number of people who used antibiotics for URTIs by about 42%; and may not increase the number of people who experienced side effects (any harm). Evidence showing a decrease in the number of people absent from childcare centre, school, or work due to acute URTIs with probiotics was very uncertain.  </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We are moderately confident that probiotics decrease the number of people diagnosed with at least three URTIs and the number of people who used antibiotics for URTIs, and have low confidence in the evidence that probiotics decrease the number of people diagnosed with at least one URTI, the incidence rate of acute URTIs, the mean duration of an episode of acute URTIs, and increase the number of people who experienced side effects (any harm). Evidence showing a decrease in the number of people absent from childcare centre, school, or work due to acute URTIs with probiotics was very uncertain. The main reasons for the limitations of the evidence were that people in the studies may have known which treatment they were getting, and not all of the studies provided data about everything that we were interested in. </p> <p><b>How up‐to‐date is the evidence?</b> </p> <p>The evidence is current to 10 May 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006895-sec-0123" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006895-sec-0123"></div> <h3 class="title" id="CD006895-sec-0124">Implications for practice</h3> <section id="CD006895-sec-0124"> <p>When compared to placebo or no treatment, probiotics may reduce the number of participants diagnosed with acute upper respiratory tract infections (URTIs) (at least one event) (low‐certainty evidence); likely reduce the number of participants diagnosed with URTIs (at least three events) (moderate‐certainty evidence); may reduce the incidence rate of acute URTIs (low‐certainty evidence); may reduce the mean duration of an episode of acute URTIs (low‐certainty evidence); likely reduce the number of participants who used antibiotics for URTIs (moderate‐certainty evidence); and may not increase the number of participants who experienced at least one adverse event (low‐certainty evidence). The evidence regarding the number of participants who were absent from childcare centre, school, or work due to acute URTIs is very uncertain. </p> </section> <h3 class="title" id="CD006895-sec-0125">Implications for research</h3> <section id="CD006895-sec-0125"> <p>Future randomised controlled trials should consider:</p> <p> <ol id="CD006895-list-0020"> <li> <p>a study design that incorporates adequate blinding and concealment of the allocation sequence; </p> </li> <li> <p>assessment of common outcomes (e.g. the number of episodes of acute URTIs and the mean duration of an episode of acute URTIs should be primary outcome measures); </p> </li> <li> <p>focusing on older people or performing a subgroup analysis of older people;</p> </li> <li> <p>adverse event outcomes: time off from childcare centre, school, or work; and</p> </li> <li> <p>cost‐effectiveness and quality of life.</p> </li> </ol> </p> <p>Additionally, studies should not be influenced by funds from manufacturers of the tested probiotics. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006895-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006895-sec-0008"></div> <div class="table" id="CD006895-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics compared to placebo or no treatment for preventing acute upper respiratory tract infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Intention‐to‐treat analysis: probiotics compared to placebo or no treatment for preventing acute upper respiratory tract infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children, adults, and the elderly </p> <p><b>Setting:</b> in the community, care facilities, school, or hospital </p> <p><b>Intervention:</b> probiotics </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo or no treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with probiotics</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who were diagnosed with acute URTIs: at least 1 event</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.76<br/>(0.67 to 0.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4798<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>447 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>340 per 1000<br/>(300 to 389) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who were diagnosed with acute URTIs: at least 3 events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.38 to 0.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>763<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1000<br/>(49 to 117) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incidence rate of acute URTIs</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rate ratio 0.82<br/>(0.73 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4364<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean duration of an episode of acute URTIs</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of an episode of URTIs in the probiotics group was 1.22 days lower<br/>(2.12 to 0.33 lower). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2406<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who were absent from childcare centre, school, or work due to acute URTIs </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.14<br/>(0.03 to 0.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d,e,f</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/>(1 to 21) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who used prescribed antibiotics for acute URTIs</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/>(0.42 to 0.81) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1548<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000<br/>(42 to 81) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who experienced at least 1 side effect or adverse event</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.02<br/>(0.90 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2456<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,g</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>233 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>238 per 1000 (210 to 268)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>URTI:</b> upper respiratory tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once for study limitations, as most information was from studies at unclear risk of bias.<br/><sup>b</sup>Downgraded once for publication bias, as the funnel plot was asymmetrical.<br/><sup>c</sup>Downgraded once for inconsistency due to the higher I<sup>2</sup> statistic (93%).<br/><sup>d</sup>Downgraded once for study limitations due to unclear risk of bias for allocation concealment and selective reporting.<br/><sup>e</sup>Downgraded once for imprecision due to the wide 95% CI.<br/><sup>f</sup>Downgraded once for indirectness, as the included study only reported school absenteeism due to the common cold.<br/><sup>g</sup>Downgraded once for imprecision, as the CI overlapped no effect. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006895-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006895-sec-0009"></div> <section id="CD006895-sec-0010"> <h3 class="title" id="CD006895-sec-0010">Description of the condition</h3> <p>Acute upper respiratory tract infections (URTIs), which include the common cold, acute sinusitis, acute pharyngitis, acute laryngotracheobronchitis (croup), acute epiglottitis (supraglottitis), acute rhinosinusitis, and acute otitis media (AOM), are a major cause of morbidity, especially in children and the elderly (<a href="./references#CD006895-bbs2-0098" title="DuijvestijnYC , MourdiN , SmucnyJ , PonsG , ChalumeauM . Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database of Systematic Reviews2009, Issue 1. Art. No: CD003124. [DOI: 10.1002/14651858.CD003124.pub3]">Duijvestijn 2009</a>; <a href="./references#CD006895-bbs2-0107" title="KasselJC , KingD , SpurlingGK . Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database of Systematic Reviews2010, Issue 3. Art. No: CD006821. [DOI: 10.1002/14651858.CD006821.pub2]">Kassel 2010</a>; <a href="./references#CD006895-bbs2-0113" title="LiberatiA , D'AmicoR , PifferiS , TorriV , BrazziL , ParmelliE . Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database of Systematic Reviews2009, Issue 4. Art. No: CD000022. [DOI: 10.1002/14651858.CD000022.pub2]">Liberati 2009</a>). They are caused by a large variety of viruses and bacteria. In the United States, acute URTIs are the most common reason for people to seek medical care (<a href="./references#CD006895-bbs2-0095" title="CherryDK , BurtCW , WoodwellDA . National ambulatory medical care survey: 2001 summary. Advance Data2003;337:1-44.">Cherry 2003</a>), and at least 1000 million colds occur there per year, with a frequency of two to six colds per person (<a href="./references#CD006895-bbs2-0104" title="Gwaltney JM Jr. Clinical significance and pathogenesis of viral respiratory infections. American Journal of Medicine2002;112(Suppl):13-8.">Gwaltney 2002</a>). </p> <p>Acute URTIs are usually mild, viral infections with symptoms subsiding after a few days. They account for up to 75.8% of all antibiotic use in high‐income countries (<a href="./references#CD006895-bbs2-0125" title="Rún SigurðardóttirN , NielsenAB , MunckA , BjerrumL . Appropriateness of antibiotic prescribing for upper respiratory tract infections in general practice: comparison between Denmark and Iceland. Scandinavian Journal of Primary Health Care2015;33(4):269-74. [DOI: 10.3109/02813432.2015.1114349]">Rún Sigurðardóttir 2015</a>). Antibiotics are often misused in acute URTIs with viral aetiologies (<a href="./references#CD006895-bbs2-0128" title="SteinmanMA , GonzalesR , LinderJA , LandefeldCS . Changing use of antibiotics in community-based outpatient practice, 1991-1999. Annals of Internal Medicine2003;738:525-33.">Steinman 2003</a>), despite the fact that the development of antibiotic‐resistant bacteria is inevitable. Although the causes of antibiotic resistance are multifactorial (<a href="./references#CD006895-bbs2-0089" title="AnderssonDI , BalabanNQ , BaqueroF , CourvalinP , GlaserP , GophnaU , et al. Antibiotic resistance: turning evolutionary principles into clinical reality. FEMS Microbiolgy Reviews2020;44(2):171-88. [DOI: 10.1093/femsre/fuaa001]">Andersson 2020</a>), antibiotic overuse is a major contributor (<a href="./references#CD006895-bbs2-0130" title="WoappiY , GabaniP , SinghA , SinghOV . Antibiotrophs: the complexity of antibiotic-subsisting and antibiotic-resistant microorganisms. Critical Reviews in Microbiology2016;42(1):17-30. [DOI: 10.3109/1040841X.2013.875982]">Woappi 2016</a>). </p> </section> <section id="CD006895-sec-0011"> <h3 class="title" id="CD006895-sec-0011">Description of the intervention</h3> <p>Probiotics, a Greek word meaning 'for life', were first described by Kollath more than 50 years ago (<a href="./references#CD006895-bbs2-0108" title="KollathW . Nutrition and the tooth system [Ernahrung und Zahnsystem]. Deutsche Zahnarztliche Zeitschrift1953;8:7-16.">Kollath 1953</a>). They are now defined as "live microorganisms administered in adequate amounts which confer a beneficial physiological effect on the host" (<a href="./references#CD006895-bbs2-0122" title="ReidG , SandersME , GaskinsHR , GibsonGR , MercenierA , RastallR , et al. New scientific paradigms for probiotics and prebiotics. Journal of Clinical Gastroenterology2003;37(2):105-18.">Reid 2003</a>). Although the underlying mechanisms of probiotics are still unclear, their application shows some promising results and trends with respect to immune modulations. Limited evidence from systematic reviews shows that probiotics are beneficial for treating infectious diarrhoea (<a href="./references#CD006895-bbs2-0094" title="Bernaola AponteG , Bada MancillaCA , CarreazoNY , Rojas GalarzaRA . Probiotics for treating persistent diarrhoea in children. Cochrane Database of Systematic Reviews2013, Issue 8. Art. No: CD007401. [DOI: 10.1002/14651858.CD007401.pub3]">Bernaola Aponte 2013</a>), preventing antibiotic‐associated diarrhoea (<a href="./references#CD006895-bbs2-0103" title="GuoQ , GoldenbergJZ , HumphreyC , El DibR , JohnstonBC . Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews2019, Issue 4. Art. No: CD004827. [DOI: 10.1002/14651858.CD004827.pub5]">Guo 2019</a>), and treating vaginal infections in pregnancy (<a href="./references#CD006895-bbs2-0117" title="OthmanM , MeilsonJP , AlfirevicZ . Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews2010, Issue 6. Art. No: CD005941. [DOI: 10.1002/14651858.CD005941.pub2]">Othman 2010</a>). </p> </section> <section id="CD006895-sec-0012"> <h3 class="title" id="CD006895-sec-0012">How the intervention might work</h3> <p>There are a number of possible means by which probiotics may improve health, one of which is the immunomodulation of local immunity (by maintaining gut wall integrity) and systemic immunity (by enhancing non‐specific and specific arms of the immune system). These include the following. </p> <p>1. Probiotics and the innate immune function</p> <p> <ul id="CD006895-list-0001"> <li> <p>Enhances phagocytic capacity of peripheral blood leucocytes (polymorphonuclear and monocytes). </p> </li> <li> <p>Improves phagocytic activity.</p> </li> <li> <p>Granulocytes show higher increases in phagocytic cell function compared with monocytes (<a href="./references#CD006895-bbs2-0096" title="Donnet-HughesA , RochatF , SerrantP , AeschlimannJM , SchifferinEJ . Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. Journal of Dairy Science1999;82(5):863-9.">Donnet‐Hughes 1999</a>; <a href="./references#CD006895-bbs2-0126" title="SchiffrinEJ , RocharF , Link-AmsterH , AeschlimannJM , Donnet-HughesA . Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. Journal of Dairy Science1995;78:491-7.">Schiffrin 1995</a>; <a href="./references#CD006895-bbs2-0127" title="SheihYH , ChiaryBL , WangLH , LiaoCK , GillHS . Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium lactobacillus rhamnosus HN001. Journal of the American College of Nutrition2001;20(Suppl 2):149-56.">Sheih 2001</a>). </p> </li> </ul> </p> <p>There are significant increases in the expression of receptors (CR1, CR3, FccRI, and FcaR) involved in phagocytosis (the cellular process of engulfing and ingesting solid particles, such as bacteria by the cell membrane) (<a href="./references#CD006895-bbs2-0118" title="PeltoL , IsolauriE , LiliusEM , NuutilaJ , SalminenS . Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clinical and Experimental Allergy1998;28(12):1474-9.">Pelto 1998</a>), the phagocytic index, oxidative burst (also known as respiratory burst, the rapid release of reactive oxygen species from some cells) (<a href="./references#CD006895-bbs2-0096" title="Donnet-HughesA , RochatF , SerrantP , AeschlimannJM , SchifferinEJ . Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. Journal of Dairy Science1999;82(5):863-9.">Donnet‐Hughes 1999</a>), and microbicidal capacity in neutrophils (<a href="./references#CD006895-bbs2-0090" title="ArunachalamK , GillHS , ChandroRK . Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). European Journal of Clinical Nutrition2000;54(3):263-7.">Arunachalam 2000</a>). Natural killer (NK) cell (a type of cytotoxic cell that constitutes an important part of the innate immune system) activity is also markedly improved, and there are increases in the percentage of NK cells in the peripheral blood (<a href="./references#CD006895-bbs2-0097" title="DrakesM , BlanchardT , CzinnS . Bacterial probiotic modulation of dendritic cell. Infection and Immunity2004;72(6):3299-309.">Drakes 2004</a>; <a href="./references#CD006895-bbs2-0110" title="LeeA , LeeYJ , YooHJ , KimM , ChangY , LeeDS , et al. Consumption of dairy yogurt containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and heat-treated Lactobacillus plantarum improves immune function including natural killer cell activity. Nutrients2017;9(6):558. [DOI: 10.3390/nu9060558]">Lee 2017</a>). </p> <p>2. Probiotics and acquired immunity</p> <p> <ul id="CD006895-list-0002"> <li> <p>Significantly higher specific IgG, IgA, and IgM immunoglobulins (<a href="./references#CD006895-bbs2-0110" title="LeeA , LeeYJ , YooHJ , KimM , ChangY , LeeDS , et al. Consumption of dairy yogurt containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and heat-treated Lactobacillus plantarum improves immune function including natural killer cell activity. Nutrients2017;9(6):558. [DOI: 10.3390/nu9060558]">Lee 2017</a>; <a href="./references#CD006895-bbs2-0114" title="Link-AmsterH , RochatF , SaudanKY , MignotO , AeschlimannJM . Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. Immunology and Medical Microbiology1994;10(1):55-63.">Link‐Amster 1994</a>; <a href="./references#CD006895-bbs2-0115" title="MajamaaH , IsolauriE , SaxelinM , VesikariT . Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. Journal of Pediatric Gastroenterology and Nutrition1995;20(3):333-8.">Majamaa 1995</a>). </p> </li> </ul> </p> <p>3. Probiotics and local immunity</p> <p> <ul id="CD006895-list-0003"> <li> <p>Enhances gut barrier function and improves the local immune response (<a href="./references#CD006895-bbs2-0119" title="PerdigonG , AlvarezS , RachidM , AgueroG , GobbatoN . Immune system stimulation by probiotics. Journal of Dairy Science1995;78(7):1597-606.">Perdigon 1995</a>). </p> </li> <li> <p>Increases the production of cytokines (e.g. interleukin‐1 (IL‐1), IL‐2, IL‐6, IL‐10, IL‐12, IL‐18, tumour necrosis factor alpha (TNF‐α), interferon‐α) (<a href="./references#CD006895-bbs2-0100" title="GillHS . Stimulation of the immune system by lactic cultures. International Dairy Journal1998;8:535-44.">Gill 1998</a>; <a href="./references#CD006895-bbs2-0110" title="LeeA , LeeYJ , YooHJ , KimM , ChangY , LeeDS , et al. Consumption of dairy yogurt containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and heat-treated Lactobacillus plantarum improves immune function including natural killer cell activity. Nutrients2017;9(6):558. [DOI: 10.3390/nu9060558]">Lee 2017</a>; <a href="./references#CD006895-bbs2-0116" title="MeydaniSN , HaWK . Immunologic effects of yogurt. American Journal of Clinical Nutrition2000;71(4):861-72.">Meydani 2000</a>; <a href="./references#CD006895-bbs2-0124" title="RossolM , HeineH , MeuschU , QuandtD , KleinC , SweetMJ , et al. LPS-induced cytokine production in human monocytes and macrophages. Critical Reviews in Immunology2011;31(5):379-446. [DOI: 10.1615/critrevimmunol.v31.i5.20]">Rossol 2011</a>). </p> </li> </ul> </p> </section> <section id="CD006895-sec-0013"> <h3 class="title" id="CD006895-sec-0013">Why it is important to do this review</h3> <p>More than a century ago, Nobel Prize winner Elie Metchnikoff conducted a series of trials showing that ingesting microbes that produce lactic acid by fermentation improves ailments such as digestive and respiratory tract disorders. The first evidence that probiotic strains could prevent respiratory tract infections was shown when mice were successfully protected against influenza through the administration of <i>Bifidobacterium breve</i> YIT4064 augmented anti‐influenza IgG (<a href="./references#CD006895-bbs2-0131" title="YasuiH , KiyosimaJ , HoriT , ShidaK . Protection against influenza infection of mice fed Bifido bacterium breve YIT 4064. Clinical and Diagnostic Laboratory Immunology1999;6:186-92.">Yasui 1999</a>). Soon after, Finnish researchers conducted trials amongst children in daycare centres who were given milk containing <i>Lactobacillus rhamnosus</i> GG (ATCC 53103) during winter (<a href="./references#CD006895-bbs2-0041" title="HatakkaK , SavilahtiE , PonkaA , MeurmanJH , PoussaT , NaseL , et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ2001;322(1298):1327-9. ">Hatakka 2001</a>). However, one study showed that the probiotics did not have any effect on upper respiratory infections after the intervention (<a href="./references#CD006895-bbs2-0042" title="HatakkaK , BlomgrenK , PohjavuoriS , KaijalainenT , PoussaT , LeinonenM , et al. Treatment of acute otitis media with probiotics in otitis-prone children - a double-blind, placebo-controlled randomised study. Clinical Nutrition2007;26(3):314-21. ">Hatakka 2007</a>). Given the increasing consumption of probiotics, we feel there is a need to fully understand the effect of probiotics on acute URTIs and their potential adverse effects in humans. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006895-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006895-sec-0014"></div> <p>To assess the effectiveness and safety of probiotics (any specified strain or dose), compared with placebo or no treatment, in the prevention of acute URTIs in people of all ages, at risk of acute URTIs. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006895-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006895-sec-0015"></div> <section id="CD006895-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006895-sec-0017"> <h4 class="title">Types of studies</h4> <p>Both individual and cluster‐RCTs (more than four clusters per group) of probiotics to prevent acute URTIs. We excluded cross‐over trials due to potential residual treatment effects. </p> </section> <section id="CD006895-sec-0018"> <h4 class="title">Types of participants</h4> <p>Children and adults of all ages from the community, care facilities, schools, or hospitals. We excluded those participants whose circumstances may have affected their immunity, including those who had taken immune‐stimulating medications, undergone abnormal physical exercise (e.g. athletes (<a href="./references#CD006895-bbs2-0102" title="GreenhamG , BuckleyJD , GarrettJ , EstonR , NortonK . Biomarkers of physiological responses to periods of intensified, non-resistance-based exercise training in well-trained male athletes: a systematic review and meta-analysis. Sports Medicine2018;48(11):2517-48. [DOI: 10.1007/s40279-018-0969-2]">Greenham 2018</a>)), or had known congenital or acquired immune defects (e.g. otitis‐prone children (<a href="./references#CD006895-bbs2-0092" title="BardouML , PontarolliD , GrumachAS . Otitis media and inborn errors of immunity. Current Allergy and Asthma Reports2020;20(10):59. [DOI: 10.1007/s11882-020-00957-x]">Bardou 2020</a>; <a href="./references#CD006895-bbs2-0120" title="PichicheroME . Ten-year study of the stringently defined otitis-prone child in Rochester, NY. Pediatric Infectious Disease Journal2016;35(9):1033-9. [DOI: 10.1097/INF.0000000000001217]">Pichichero 2016</a>; <a href="./references#CD006895-bbs2-0121" title="PichicheroME . Immunologic dysfunction contributes to the otitis prone condition. Journal of Infection2020;80(6):614-22. [DOI: 10.1016/j.jinf.2020.03.017]">Pichichero 2020</a>)) or allergies. We excluded studies that did not specify acute respiratory infections as 'upper'. We also excluded studies where more than 50% of participants had been vaccinated against influenza or other acute URTIs within the last 12 months, as vaccines will be an important effect modification factor. We also excluded studies that had significantly different proportions of vaccinated participants between the probiotics arm and the placebo or no treatment arm. </p> </section> <section id="CD006895-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Any probiotic (single or mixture of strains, any dosage regimen and any route of administration) for more than seven days, compared to placebo or no treatment. </p> </section> <section id="CD006895-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We only included the studies that specified acute respiratory infections as 'upper'. Cases of acute URTIs should have been confirmed by doctors, or have specific symptoms, such as nasal symptoms (e.g. runny nose, blocked nose, nose blowing, yellow secretions, bloody secretions, sneezing), pharyngeal symptoms (e.g. scratchy throat, sore throat, hoarseness), tonsillitis or pharyngitis (e.g. pain on swallowing, sore throat), laryngitis (e.g. hoarseness), and bronchial symptoms (e.g. cough, secretions), as well as headache, myalgia, red eyes (conjunctivitis), and fever (oral temperature &gt; 37.7 °C or rectal temperature &gt; 38 °C). </p> <section id="CD006895-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006895-list-0004"> <li> <p>Number of participants who were diagnosed with acute URTIs.</p> </li> <li> <p>Incidence rate (number of cases/person year) of acute URTIs.</p> </li> <li> <p>Mean duration of an episode of acute URTIs.</p> </li> </ol> </p> </section> <section id="CD006895-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006895-list-0005"> <li> <p>Number of participants who were absent from childcare centre, school, or work (a proxy of severity of disease). </p> </li> <li> <p>Number of participants who used antibiotics for URTIs (a proxy of severity of disease).</p> </li> <li> <p>Number of participants who experienced at least one side effect or adverse event.</p> </li> </ol> </p> </section> </section> </section> <section id="CD006895-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006895-sec-0024"> <h4 class="title">Electronic searches</h4> <p>For this 2022 update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2022, Issue 6) (accessed 10 May 2022), which includes the Cochrane Acute Respiratory Infections Group's Specialised Register; MEDLINE (July 2014 to May week 2, 2022); Embase (July 2014 to 10 May 2022); Web of Science (July 2014 to 10 May 2022); the Chinese Biomedical Literature Database, which includes the China Biological Medicine Database (from 1978 to 10 May 2022), the Chinese Medicine Popular Science Literature Database (from 2000 to 10 May 2022), and the Master's Degree Dissertation of Beijing Union Medical College Database (from 1981 to 10 May 2022). We used the search strategy described in <a href="./appendices#CD006895-sec-0129">Appendix 1</a> to search MEDLINE and CENTRAL. We combined the MEDLINE search strategy with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version, Ovid format (<a href="./references#CD006895-bbs2-0111" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Lefebvre 2011</a>). We adapted the search strategy to search Embase (<a href="./appendices#CD006895-sec-0130">Appendix 2</a>), Web of Science (<a href="./appendices#CD006895-sec-0131">Appendix 3</a>), and the Chinese Biomedical Literature Database (<a href="#CD006895-fig-0001">Figure 1</a>). See <a href="./appendices#CD006895-sec-0132">Appendix 4</a> for details of previous searches. </p> <div class="figure" id="CD006895-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Chinese Biomedical Literature Database search strategy." data-id="CD006895-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-01.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Chinese Biomedical Literature Database search strategy.</p> </div> </div> </div> </section> <section id="CD006895-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We also searched the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>) and ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>) for completed and ongoing trials on 10 May 2022. We searched the reference sections of review articles to identify trials missed by electronic searching. We contacted the first author of the included trials and the manufacturers of probiotic agents and authors of conference literature for additional published or unpublished data. We did not impose any language or publication restrictions in the searches. </p> </section> </section> <section id="CD006895-sec-0026"> <h3 class="title" id="CD006895-sec-0026">Data collection and analysis</h3> <section id="CD006895-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (YZ, QH) independently performed title and abstract screening and full‐text review of studies identified by the search. We included trials using probiotic preparations containing other substances, such as vitamins and minerals, if these were also part of the placebo or no treatment arm. Any disagreements were resolved by discussion or by consulting a third review author (BD) when necessary. We discussed titles or abstracts not available in English with translators. </p> </section> <section id="CD006895-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (YZ, QH) independently extracted data from the included trials using the Cochrane Acute Respiratory Infection Group's data extraction form. We extracted the following data: </p> <p> <ol id="CD006895-list-0006"> <li> <p>author;</p> </li> <li> <p>year of publication;</p> </li> <li> <p>language;</p> </li> <li> <p>authors' institutions;</p> </li> <li> <p>participants (age range, gender, inclusion and exclusion criteria);</p> </li> <li> <p>methodological design (methods of randomisation, allocation concealment, blinding, loss to follow‐up and intention‐to‐treat analysis (ITT)); </p> </li> <li> <p>details of intervention (single or mixture of strains, dosage regimen, route of administration, duration, comparison treatment); </p> </li> <li> <p>results (i.e. incidence of acute URTIs, reasons for withdrawal, measures of compliance and adverse effects, etc.). </p> </li> </ol> </p> <p>Any disagreements were resolved by discussion or by consulting a third review author (BD) when necessary. We contacted trial authors and pharmaceutical companies to clarify unclear data and to request additional information on methodological certainty. </p> </section> <section id="CD006895-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (QH, BD) independently assessed methodological certainty, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006895-bbs2-0105" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). For trials using individual randomisation, we considered random sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting, and other bias. For trials using cluster randomisation, we assessed recruitment bias, baseline imbalance, loss of clusters, incorrect analysis and comparability with individually randomised trials. </p> <section id="CD006895-sec-0030"> <h5 class="title">Random sequence generation</h5> <p> <ol id="CD006895-list-0007"> <li> <p>Low risk of bias: adequate generation of allocation sequence (e.g. computer‐generated random numbers, table of random numbers, or similar). </p> </li> <li> <p>High risk of bias: inadequate generation of allocation sequence (case record number; date of birth, day, month or year of admission (<a href="./references#CD006895-bbs2-0105" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>); or allocation by judgement of the clinician, the participant, laboratory test or a series of tests, availability of the intervention). </p> </li> <li> <p>Unclear risk of bias: the generation of the allocation sequence was unclear.</p> </li> </ol> </p> </section> <section id="CD006895-sec-0031"> <h5 class="title">Allocation concealment</h5> <p> <ol id="CD006895-list-0008"> <li> <p>Low risk of bias: adequate concealment of allocation (e.g. central independent unit, non‐translucent sealed envelopes, or similar). </p> </li> <li> <p>High risk of bias: inadequate concealment of allocation (any procedure that is transparent before allocation, e.g. alternation, the use of case record numbers, dates of birth, or open table of random numbers or similar). </p> </li> <li> <p>Unclear risk of bias: unclear concealment of allocation (e.g. only specifying that non‐translucent sealed envelopes were used or not reporting any concealment approach) or inadequate. </p> </li> </ol> </p> </section> <section id="CD006895-sec-0032"> <h5 class="title">Blinding of participants and personnel </h5> <p> <ol id="CD006895-list-0009"> <li> <p>Low risk of bias: we considered masking of both the participants and study personnel who implemented the study to be low risk of performance bias (e.g. identical placebo tablets or similar, and the study personnel did not know the groups). </p> </li> <li> <p>High risk of bias: open‐label study.</p> </li> <li> <p>Unclear risk of bias: insufficient information provided to judge the level of bias.</p> </li> </ol> </p> </section> <section id="CD006895-sec-0033"> <h5 class="title">Blinding of outcome assessment</h5> <p> <ol id="CD006895-list-0010"> <li> <p>Low risk of bias: we considered masking of the outcome assessor to be low risk of detection bias. </p> </li> <li> <p>High risk of bias: not used or non‐blinding of detection of outcomes (e.g. not performed or tablets versus fluids or similar). </p> </li> <li> <p>Unclear risk of bias: insufficient information provided to judge the level of bias.</p> </li> </ol> </p> </section> <section id="CD006895-sec-0034"> <h5 class="title">Incomplete outcome data: assessment for potential bias of exclusion and attrition</h5> <p> <ol id="CD006895-list-0011"> <li> <p>Low risk of bias: trials had no missing outcome data or few exclusions; attrition is noted; and an ITT analysis is possible. </p> </li> <li> <p>High risk of bias: there are wide differences in exclusions between the intervention group and the control group, or the rate of exclusion and/or attrition is higher than 15%, whatever ITT analysis is used. </p> </li> <li> <p>Unclear risk of bias: the rate of exclusions or attrition, or both, is higher than 10%, whatever ITT analysis is used. </p> </li> </ol> </p> </section> <section id="CD006895-sec-0035"> <h5 class="title">Selective reporting</h5> <p> <ol id="CD006895-list-0012"> <li> <p>If a protocol for the included study was available, we compared the outcomes in the protocol and those in the published report. </p> </li> </ol> </p> </section> <section id="CD006895-sec-0036"> <h5 class="title">Other bias</h5> <p> <ol id="CD006895-list-0013"> <li> <p>Any other potential biases.</p> </li> </ol> </p> </section> <section id="CD006895-sec-0037"> <h5 class="title">Recruitment bias</h5> <p> <ol id="CD006895-list-0014"> <li> <p>Low risk of bias: the clusters were randomised after individuals recruiting.</p> </li> <li> <p>High risk of bias: the clusters were randomised before individuals recruiting.</p> </li> <li> <p>Unclear risk of bias: insufficient information provided to judge the level of bias.</p> </li> </ol> </p> </section> <section id="CD006895-sec-0038"> <h5 class="title">Baseline imbalance</h5> <p> <ol id="CD006895-list-0015"> <li> <p>Low risk of bias: the trials used stratified or pair‐matched randomisation of clusters; or the trials reported the baseline comparability of clusters, or statistical adjustment for baseline characteristics. </p> </li> <li> <p>High risk of bias: the trials did not use stratified or pair‐matched randomisation of clusters. In addition, the trials did not report the baseline comparability of clusters and statistical adjustment for baseline characteristics. </p> </li> <li> <p>Unclear risk of bias: insufficient information provided to judge the level of bias.</p> </li> </ol> </p> </section> <section id="CD006895-sec-0039"> <h5 class="title">Loss of clusters</h5> <p> <ol id="CD006895-list-0016"> <li> <p>Complete clusters were lost from a trial, and had to be omitted from the analysis. In addition, missing outcomes for individuals within clusters led to risk of bias. </p> </li> </ol> </p> </section> <section id="CD006895-sec-0040"> <h5 class="title">Incorrect analysis</h5> <p> <ol id="CD006895-list-0017"> <li> <p>The trials were analysed by incorrect statistical methods and did not take the clustering into account. </p> </li> </ol> </p> </section> <section id="CD006895-sec-0041"> <h5 class="title">Comparability with individually randomised trials</h5> <p> <ol id="CD006895-list-0018"> <li> <p>The intervention effects were different from individually randomised trials.</p> </li> </ol> </p> </section> </section> <section id="CD006895-sec-0042"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed data using Review Manager Web (<a href="./references#CD006895-bbs2-0123" title="Review Manager Web (RevMan Web). Version 4.7.1. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>). We were only able to perform limited pooled analyses. We used a random‐effects model for pooled analysis of both heterogeneous data and homogeneous data. We expressed results as risk ratios (RRs) for dichotomous outcomes and mean differences (MDs) for continuous outcomes, both with 95% confidence intervals (CIs). If the study reported the incidence rate (number of cases/person year) of URTIs using a mixed model, we would choose its effect size; otherwise, we would calculate the incidence rate of URTIs between groups and the standard error (SE) of the rate ratio according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006895-bbs2-0106" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchV , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). We used the generic inverse‐variance weighting when pooling trials for this outcome. When the cluster‐randomised trials failed to conduct appropriate analyses and did not report their effective sample sizes, we would recalculate the design effects and the number of events. We used the intracluster correlation coefficient (ICC = 0.02) and the number of clusters to calculate the design effects and the number of events. We reported the adjusted sample sizes and numbers of events in the meta‐analyses. </p> </section> <section id="CD006895-sec-0043"> <h4 class="title">Unit of analysis issues</h4> <p>We did not anticipate including cross‐over trials in this review. We combined similar groups to create a single pair‐wise comparison for multiple arms from one study according to the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006895-bbs2-0106" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchV , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). We also took care to avoid double‐counting of participants where multiple interventions were used in the same trial. </p> </section> <section id="CD006895-sec-0044"> <h4 class="title">Dealing with missing data</h4> <p>We sought missing data from the trial authors. We analysed the outcome measures both in an ITT population (i.e. we considered participants who dropped out of a study along with those who continued) and a per‐protocol (PP) population (i.e. we excluded participants who dropped out of a study during the follow‐up period). If the study only reported data for the PP population, we imputed the missing values using single imputations and borrowed information from probiotics and placebo and no treatment group separately in ITT analysis. </p> </section> <section id="CD006895-sec-0045"> <h4 class="title">Assessment of heterogeneity</h4> <p>We carried out tests for heterogeneity using the Chi<sup>2</sup> test, with significance being set at P &lt; 0.1. We used the I<sup>2</sup> statistic to estimate the total variation across trials according to the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006895-bbs2-0106" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchV , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>): an I<sup>2</sup> statistic &lt; 40% might not be important heterogeneity; 30% to 60% may represent a moderate level of heterogeneity; 50% to 90% a substantial level of heterogeneity; and 75% to 100% a considerable level of heterogeneity. </p> </section> <section id="CD006895-sec-0046"> <h4 class="title">Assessment of reporting biases</h4> <p>We used funnel plots to assess the presence of publication bias where at least 10 studies contributed to the meta‐analysis (<a href="./references#CD006895-bbs2-0099" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34. [DOI: 10.1136/bmj.315.7109.629]">Egger 2007</a>). We assessed funnel plot asymmetry visually. When there was asymmetry in the funnel plots, we would add contour‐enhanced funnel plots to differentiate the asymmetry that was due to non‐reporting biases or other factors (<a href="./references#CD006895-bbs2-0106" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchV , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). </p> </section> <section id="CD006895-sec-0047"> <h4 class="title">Data synthesis</h4> <p>We used a random‐effects model to synthesise all data, irrespective of heterogeneity between the pooled trials. </p> </section> <section id="CD006895-sec-0048"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We explored possible explanations for heterogeneity by conducting the following subgroup analyses: </p> <p> <ol id="CD006895-list-0019"> <li> <p>age (children versus adults versus elderly);</p> </li> <li> <p>treatment dose (less than 10<sup>10</sup> colony‐forming units (CFU) per day versus more than 10<sup>10</sup> CFU per day); </p> </li> <li> <p>treatment duration (less than three months versus three to six months versus more than six months); </p> </li> <li> <p>comparator (placebo versus no treatment).</p> </li> </ol> </p> </section> <section id="CD006895-sec-0049"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analysis by excluding trials at high risk of bias and cluster‐RCTs.</p> </section> <section id="CD006895-sec-0050"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We only included RCTs, and downgraded the certainty of the evidence from high certainty by one level for serious (or by two for very serious) study limitations (risk of bias), indirectness of evidence, inconsistency, imprecision of effect estimates, or potential publication bias, according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006895-bbs2-0106" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchV , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>)<i>.</i> Furthermore, we used GRADEpro GDT to create a summary of findings table, and reported primary and secondary outcomes based on an ITT population (<a href="./references#CD006895-bbs2-0101" title="GRADEpro GDT. Version accessed 20 May 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). </p> <p>We created one summary of findings table using the following outcomes: number of participants who were diagnosed with acute URTIs (at least one event); number of participants who were diagnosed with acute URTIs (at least three events); incidence rate of acute URTIs; mean duration of an episode of acute URTIs; number of participants who were absent from childcare centre, school, or work due to acute URTIs; number of participants who used antibiotics for acute URTIs; number of participants who experienced at least one side effect or adverse event (<a href="./full#CD006895-tbl-0001">summary of findings Table 1</a>). We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of a body of evidence as it relates to the studies which contribute data to the meta‐analyses for the prespecified outcomes (<a href="./references#CD006895-bbs2-0091" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490.">Atkins 2004</a>). We used the methods and recommendations described in part 2 and Chapter 14 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using GRADEpro GDT (<a href="./references#CD006895-bbs2-0101" title="GRADEpro GDT. Version accessed 20 May 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>) (<a href="./references#CD006895-bbs2-0106" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchV , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). We justified all decisions to down‐ or upgrade the certainty of the evidence using footnotes, and made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006895-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006895-sec-0051"></div> <section id="CD006895-sec-0052"> <h3 class="title">Description of studies</h3> <section id="CD006895-sec-0053"> <h4 class="title">Results of the search</h4> <p>We retrieved records from CENTRAL (517 records), MEDLINE (696 records), Embase (717 records), Web of Science (692 records), and the Chinese Biomedical Literature Database (13 records) in our electronic literature searches. After de‐duplication, 1731 records remained. We excluded 1646 records based on title and abstract, and retrieved 85 full‐text articles. We eventually included 24 trials in the review (<a href="#CD006895-fig-0002">Figure 2</a>). We also retrieved 113 registered trials from WHO ICTRP and ClinicalTrials.gov, and identified one ongoing trial for this review after assessment (<a href="./references#CD006895-sec-0149" title="">Characteristics of ongoing studies</a> table). </p> <div class="figure" id="CD006895-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006895-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006895-sec-0054"> <h4 class="title">Included studies</h4> <p>We identified 85 full texts of clinical trials and included 23 individual RCTs (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>), and one cluster‐RCT (<a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>). We also reassessed the previously included trials. We extracted and pooled data from 23 trials; we did not pool data from <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a> because the outcomes were not reported in a usable way. </p> <section id="CD006895-sec-0055"> <h5 class="title">Design</h5> <p>Most of the included RCTs used a two‐arm parallel design (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). Only two trials used a multi‐arm design (<a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>). </p> </section> <section id="CD006895-sec-0056"> <h5 class="title">Participants</h5> <p>Seven trials focused on adults aged 18 to 65 years (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>); three trials focused on older people (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>); and the remaining studies focused on children (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Trials were performed in Italy (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>), Japan (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>), the United States (<a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>), Croatia (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>), England (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>), Finland (<a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>), Sweden (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>), Chile (<a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>), China (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>), Denmark (<a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>), Germany (<a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>), Thailand (<a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>), and Turkey (<a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>). It was not clear in which countries the other two trials were conducted (<a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). Baseline data were stated, and comparability was analysed in all trials except one (<a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>). One trial reported 22.5% flu‐vaccine participants within the last 12 months and 25.4% flu‐vaccine participants during the intervention. </p> </section> <section id="CD006895-sec-0057"> <h5 class="title">Funding sources and potential conflicts of interest</h5> <p>Four trials did not disclose funding sources (<a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Three trials reported that they had received no financial support (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>). Fifteen studies received funding to support the research (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>), and 10 trials received funding from the company that produced the probiotics (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>). Nine trials stated that they had no conflicts of interest (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>), and six trials did not make declarations of interest (<a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>). Nine trials reported conflicts of interest (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>): four trials reported that the authors had received a grant from the project/company (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>), and seven trials reported that at least one author was an employee of the company that produced the probiotics (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>). </p> </section> <section id="CD006895-sec-0058"> <h5 class="title">Setting</h5> <p>Studies were conducted in various clinical settings, including the community (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>), childcare centre (<a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>), hospital (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>), well‐baby clinic (<a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>), school (<a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>), and care home for the elderly (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>). </p> </section> <section id="CD006895-sec-0059"> <h5 class="title">Interventions</h5> <p>The included trials involved different types of probiotics including <i>Lactobacillus plantarum</i> HEAL9, <i>Lactobacillus paracasei</i> (8700:2 or N1115), <i>Lactobacillus rhamnosus</i> (GG or HN001), <i>Lactobacillus casei</i> strain Shirota, <i>Lactobacillus bulgaricus</i> OLL 073R‐1, <i>Lactobacillus acidophilus</i> , <i>Lactobacillus gasseri</i> , <i>Lactobacillus helveticus</i> , <i>Streptococcus thermophilus</i> OLS 3059, <i>Bifidobacterium lactis</i> BB‐12, <i>Bifidobacterium bifidum</i> (MF 20/5 or R0071), <i>Bifidobacterium animalis</i> and <i>Bifidobacterium longum</i> (SP 07/3 or ssp. infantis R0033), <i>Streptococcus salivarius</i> 24SMB, and <i>Streptococcus oralis</i> 89a, usually compared with placebo. Most probiotics were given along with milk‐based food (<a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>). The probiotics were administered in powder form in seven studies (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>); in capsules in three studies (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>); in drops in one study (<a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>); in tablets in one study (<a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>); and in oral spray in one study (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>). Three strains of probiotics were used in two trials (<a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>); two strains of probiotics were used in 11 trials (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>); and only one strain of probiotic was used in 11 trials (<a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Most trials were conducted for three to six months. One trial used probiotics for the duration of hospitalisation (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>); one trial administered the probiotics for 8 to 12 weeks (<a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>); one trial administered the probiotics for one month (<a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>); and six trials administered the probiotics for six months or longer (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Most trials used 10<sup>9</sup> or 10<sup>11</sup> CFU/day of probiotics, with the exception of one study which used 5 × 10<sup>7</sup> CFU/day of probiotics (<a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). Most trials used a placebo, with the exception of two trials which compared the intervention with no treatment (<a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>). The study period in most trials included the common‐cold season (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). Two trials took place in summer/autumn (<a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>), and one trial did not report the season in which it was conducted (<a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>). </p> </section> <section id="CD006895-sec-0060"> <h5 class="title">Outcome measures</h5> <p>The included trials reported different outcome measures. Most trials reported the number of participants who were diagnosed with acute URTIs or the duration of acute URTI episodes (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). The incidence rate (number of cases/person year) of acute URTIs was calculated in 12 trials (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>). The outcome measures also included symptoms of unrelated diseases and infections. Six trials reported the number of participants who used prescribed antibiotics for acute URTIs (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>). Eight trials reported side effects including vomiting, diarrhoea, flatulence, and increased bowel irritability (pain, loose stools, etc.) (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>). One trial assessed the number of children who were absent from school due to the common cold (<a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>). None of the trials assessed time off from childcare centres or work due to acute URTIs. One trial reported the number of days absent from daycare centres due to "infections", but the trial did not separate URTIs from "infections" (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>). </p> </section> </section> <section id="CD006895-sec-0061"> <h4 class="title">Excluded studies</h4> <p>We excluded 61 trials for the reasons documented in the <a href="./references#CD006895-sec-0147" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD006895-sec-0062"> <h3 class="title">Risk of bias in included studies</h3> <p>The overall risk of bias is presented graphically in <a href="#CD006895-fig-0003">Figure 3</a> and summarised in <a href="#CD006895-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD006895-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD006895-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006895-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006895-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD006895-sec-0063"> <h4 class="title">Allocation</h4> <p>Sixteen trials clearly described adequate sequence generation methods (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Seven trials did not describe the sequence generation method. Seven trials described adequate allocation concealment (<a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>), and one trial was at high risk of bias for allocation concealment (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>). We approached the authors of the remaining trials for further clarification on allocation, but did not receive any replies. </p> </section> <section id="CD006895-sec-0064"> <h4 class="title">Blinding</h4> <p>Seventeen trials reported double‐blinding (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>), and 11 trials described the blinding methods in detail (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). Five trials did not report the type of blinding (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>), and one trial reported non‐blinding (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>). </p> </section> <section id="CD006895-sec-0065"> <h4 class="title">Incomplete outcome data</h4> <p>All trials provided sufficient information to permit calculation of incomplete outcome data, or described the withdrawal rate. Withdrawal rates varied from 0 (<a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>), to 42% (<a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>). Fifteen trials were at low risk of attrition bias (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>); one study was at high risk of attrition bias (<a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>); and the other seven trials were at unclear risk of attrition bias (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). </p> </section> <section id="CD006895-sec-0066"> <h4 class="title">Selective reporting</h4> <p>We only had access to protocols for four of the included trials, and these trials had a low risk of selective reporting bias (<a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>). We could not obtain the protocols for the remaining trials, which precluded an assessment of their risk of selective reporting bias. </p> </section> <section id="CD006895-sec-0067"> <h4 class="title">Other potential sources of bias</h4> <p>We did not identify any other obvious sources of bias, therefore we judged this category as low risk for each of the individual RCTs. </p> </section> <section id="CD006895-sec-0068"> <h4 class="title">Risk of bias for cluster‐RCTs</h4> <p><a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a> had a low risk of recruitment bias, baseline imbalance, loss of clusters, incorrect analysis, and comparability with individually randomised trials. </p> </section> </section> <section id="CD006895-sec-0069"> <h3 class="title" id="CD006895-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD006895-tbl-0001"><b>Summary of findings 1</b> Intention‐to‐treat analysis: probiotics compared to placebo or no treatment for preventing acute upper respiratory tract infections</a> </p> <p>We meta‐analysed 23 trials with a total of 6950 participants. We analysed all outcome measures based on both an ITT population (i.e. all participants who dropped out of the study were analysed according to their original group, irrespective of whether they had completed or received that treatment) and a PP population (i.e. participants who dropped out of a study during the follow‐up period were excluded). As the inference of PP analysis was the same as ITT analysis, we only reported ITT analysis results in the main text.  </p> <section id="CD006895-sec-0070"> <h4 class="title">Intention‐to‐treat analysis</h4> <section id="CD006895-sec-0071"> <h5 class="title">Primary outcomes</h5> <section id="CD006895-sec-0072"> <h6 class="title">1.1. Number of participants who were diagnosed with acute URTIs (at least one event)</h6> <p>Sixteen trials reported participants who experienced episodes of acute URTIs (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). There were 2539 participants in the probiotics group and 2259 participants in the placebo or no treatment group. All trials reported the number of participants who were diagnosed with acute URTIs (at least one event).  </p> </section> <section id="CD006895-sec-0073"> <h6 class="title">Age</h6> <p>Five studies were conducted in adults, and the results showed that probiotics supplementation was negatively associated with the number of participants who were diagnosed with acute URTIs (at least one event) (RR 0.77, 95% CI 0.65 to 0.93; P = 0.006; 2132 participants; <a href="./references#CD006895-fig-0007" title="">Analysis 1.1</a>) (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>). Ten trials were conducted in children and showed that the probiotics intervention was better than placebo or no treatment (RR 0.72, 95% CI 0.58 to 0.89; P = 0.003; 2512 participants; <a href="./references#CD006895-fig-0007" title="">Analysis 1.1</a>) (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Only one study was conducted on the elderly (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>). The results showed that there was no difference between the probiotics group and the placebo group in terms of the number of older adults who were diagnosed with acute URTIs (at least one event (RR 0.99, 95% CI 0.68 to 1.45; P = 0.98; 154 participants; <a href="./references#CD006895-fig-0007" title="">Analysis 1.1</a>).  </p> </section> <section id="CD006895-sec-0074"> <h6 class="title">Treatment dose</h6> <p>Eleven trials used probiotics less than 10<sup>10</sup> CFU/day (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>), and five trials used more than 10<sup>10</sup> CFU/day (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). The results showed that probiotics supplementation was negatively associated with the number participants who were diagnosed with acute URTIs (at least one event) for the dose of less than 10<sup>10</sup> CFU/day (RR 0.77, 95% CI 0.67 to 0.90; P &lt; 0.001; 4121 participants; <a href="./references#CD006895-fig-0008" title="">Analysis 1.2</a>) and the dose of more than 10<sup>10</sup> CFU/day (RR 0.70, 95% CI 0.50 to 0.99; P = 0.04; 677 participants; <a href="./references#CD006895-fig-0008" title="">Analysis 1.2</a>). </p> </section> <section id="CD006895-sec-0075"> <h6 class="title">Treatment duration</h6> <p>Two trials were conducted for less than three months (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>); nine trials for three to six months (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>); and five trials for more than six months (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). The results showed that probiotics were beneficial for preventing the occurrence of at least one episode of URTIs for both less than three months (RR 0.60, 95% CI 0.50 to 0.74; P &lt; 0.001; 381 participants; <a href="./references#CD006895-fig-0009" title="">Analysis 1.3</a>) and three to six months (RR 0.81, 95% CI 0.71 to 0.93; P = 0.003; 3704 participants; <a href="./references#CD006895-fig-0009" title="">Analysis 1.3</a>), but not for more than six months (RR 0.78, 95% CI 0.53 to 1.13; P = 0.19; 713 participants; <a href="./references#CD006895-fig-0009" title="">Analysis 1.3</a>).  </p> </section> <section id="CD006895-sec-0076"> <h6 class="title">Comparator</h6> <p>Fourteen placebo‐controlled trials, <a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>, and two trials with no treatment as the control, <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>, showed that probiotics supplementation may reduce the number participants diagnosed with acute URTIs (at least one event) (placebo: RR 0.78, 95% CI 0.68 to 0.90; P &lt; 0.001; 4465 participants; no treatment: RR 0.63, 95% CI 0.49 to 0.81; P &lt; 0.001; 333 participants; <a href="./references#CD006895-fig-0010" title="">Analysis 1.4</a>).  </p> </section> <section id="CD006895-sec-0077"> <h6 class="title">Overall pooled results</h6> <p>Pooling of these 16 trials showed a benefit of using probiotics to prevent the occurrence of at least one episode of URTIs (RR 0.76, 95% CI 0.67 to 0.87; P &lt; 0.001; 4798 participants; <a href="./references#CD006895-fig-0007" title="">Analysis 1.1</a>; <a href="./references#CD006895-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD006895-fig-0009" title="">Analysis 1.3</a>; <a href="./references#CD006895-fig-0010" title="">Analysis 1.4</a>). The contour‐enhanced funnel plot suggested that some studies with negative outcomes might be missing (<a href="#CD006895-fig-0005">Figure 5</a>). The level of heterogeneity between trials was high (Chi<sup>2</sup> = 50.94; df = 15, P &lt; 0.001; I<sup>2</sup> = 71%; <a href="./references#CD006895-fig-0007" title="">Analysis 1.1</a>; <a href="./references#CD006895-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD006895-fig-0009" title="">Analysis 1.3</a>; <a href="./references#CD006895-fig-0010" title="">Analysis 1.4</a>). We downgraded the certainty of evidence from high to low for this outcome due to study limitations and publication bias.  </p> <div class="figure" id="CD006895-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the number of participants who were diagnosed with acute URTIs: at least 1 event." data-id="CD006895-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the number of participants who were diagnosed with acute URTIs: at least 1 event. </p> </div> </div> </div> </section> <section id="CD006895-sec-0078"> <h6 class="title">1.2. Number of participants who were diagnosed with acute URTIs (at least three events)</h6> <p>Four trials reported participants who were diagnosed with acute URTIs (at least three events) (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>). There were 375 participants in the probiotics group and 388 participants in the placebo or no treatment group.  </p> </section> <section id="CD006895-sec-0079"> <h6 class="title">Age</h6> <p>Two trials were conducted in adults (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>), and two in children (<a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>). Neither group showed that probiotics made a difference in preventing the occurrence of at least three episodes of URTIs (adults: RR 0.62, 95% CI 0.20 to 1.93; P = 0.41; 551 participants; children: RR 0.64, 95% CI 0.36 to 1.14; P = 0.13; 212 participants; <a href="./references#CD006895-fig-0011" title="">Analysis 1.5</a>). </p> </section> <section id="CD006895-sec-0080"> <h6 class="title">Treatment dose</h6> <p>Two trials using probiotics of less than 10<sup>10</sup> CFU/day showed that probiotics were better than placebo (RR 0.59, 95% CI 0.36 to 0.96; P = 0.03; 449 participants; <a href="./references#CD006895-fig-0012" title="">Analysis 1.6</a>) (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>), but not in trials using probiotics of more than 10<sup>10</sup> CFU/day (RR 0.64, 95% CI 0.20 to 2.04; P = 0.45; 314 participants; <a href="./references#CD006895-fig-0012" title="">Analysis 1.6</a>) (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>).  </p> </section> <section id="CD006895-sec-0081"> <h6 class="title">Treatment duration</h6> <p>Three trials used probiotics for three to six months (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>), and one trial used probiotics for more than six months (<a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>). Benefits of probiotics for preventing the occurrence of at least three episodes of URTIs were found for the treatment duration of three to six months (three to six months: RR 0.61, 95% CI 0.38 to 0.99; P = 0.05; 682 participants; more than six months: RR 0.51, 95% CI 0.20 to 1.35; P = 0.18; 81 participants; <a href="./references#CD006895-fig-0013" title="">Analysis 1.7</a>). </p> </section> <section id="CD006895-sec-0082"> <h6 class="title">Comparator</h6> <p>Three placebo‐controlled trials showed that probiotics reduced the number of participants who were diagnosed with acute URTIs (at least three events) (RR 0.57, 95% CI 0.37 to 0.89; P = 0.01; 530 participants; <a href="./references#CD006895-fig-0014" title="">Analysis 1.8</a>) (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>), whilst one trial that used no treatment as the comparator showed no difference between groups in reducing the number of participants diagnosed with acute URTIs (at least three events) (RR 3.08, 95% CI 0.13 to 74.78; P = 0.49; 233 participants; <a href="./references#CD006895-fig-0014" title="">Analysis 1.8</a>) (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>). </p> </section> <section id="CD006895-sec-0083"> <h6 class="title">Overall pooled results</h6> <p>We found a beneficial effect of probiotics for the outcome number of participants diagnosed with acute URTIs (at least three events) (RR 0.59, 95% CI 0.38 to 0.91; P = 0.02; 763 participants; <a href="./references#CD006895-fig-0011" title="">Analysis 1.5</a>; <a href="./references#CD006895-fig-0012" title="">Analysis 1.6</a>; <a href="./references#CD006895-fig-0013" title="">Analysis 1.7</a>; <a href="./references#CD006895-fig-0014" title="">Analysis 1.8</a>). The level of heterogeneity between these trials was high (Chi<sup>2</sup> = 1.64; df = 3, P = 0.65; I<sup>2</sup> = 0%; <a href="./references#CD006895-fig-0011" title="">Analysis 1.5</a>; <a href="./references#CD006895-fig-0012" title="">Analysis 1.6</a>; <a href="./references#CD006895-fig-0013" title="">Analysis 1.7</a>; <a href="./references#CD006895-fig-0014" title="">Analysis 1.8</a>). We downgraded the certainty of the evidence from high to moderate due to study limitations. </p> </section> <section id="CD006895-sec-0084"> <h6 class="title">2. Incidence rate of acute URTIs</h6> <p>Twelve trials reported the total number of episodes of acute URTIs or the incidence of acute URTIs (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>). To perform group comparisons, we calculated the incidence ratio of episode rates (events per person/year) of acute URTIs between the probiotic and placebo or no treatment groups, and the standard error (SE) of the rate ratio according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006895-bbs2-0106" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchV , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). There were 2320 participants in the probiotics group and 2044 participants in the placebo or no treatment group.  </p> </section> <section id="CD006895-sec-0085"> <h6 class="title">Age</h6> <p>Four studies were conducted in an adult population (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>). The results showed that the probiotics intervention was better than placebo or no treatment (rate ratio 0.79, 95% CI 0.71 to 0.89; P &lt; 0.001; 2032 participants; <a href="./references#CD006895-fig-0015" title="">Analysis 1.9</a>). Six studies were conducted in children, and showed that the probiotics intervention was better than placebo (rate ratio 0.79, 95% CI 0.65 to 0.96; P = 0.02; 1868 participants; <a href="./references#CD006895-fig-0015" title="">Analysis 1.9</a>) (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>). Two studies were conducted in older people, and showed no association between probiotic intervention and incidence rate of acute URTIs (rate ratio 1.04, 95% CI 0.63 to 1.71; P = 0.88; 464 participants; <a href="./references#CD006895-fig-0015" title="">Analysis 1.9</a>) (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>).  </p> </section> <section id="CD006895-sec-0086"> <h6 class="title">Treatment dose</h6> <p>Seven trials administered the probiotics less than 10<sup>10</sup> CFU/day, and showed that probiotics reduced the incidence rate of acute URTIs (rate ratio 0.77, 95% CI 0.65 to 0.91; P = 0.002; 2631 participants; <a href="./references#CD006895-fig-0016" title="">Analysis 1.10</a>) (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>). Five trials administered the probiotics more than 10<sup>10</sup> CFU/day, and showed that probiotics did not reduce the incidence rate of acute URTIs (rate ratio 0.91, 95% CI 0.75 to 1.11; P = 0.34; 1733 participants; <a href="./references#CD006895-fig-0016" title="">Analysis 1.10</a>) (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>).  </p> </section> <section id="CD006895-sec-0087"> <h6 class="title">Treatment duration</h6> <p>Ten trials were conducted for three to six months, and showed that antibiotics reduced the incidence rate of acute URTIs (rate ratio 0.79, 95% CI 0.70 to 0.90; P &lt; 0.001; 3900 participants; <a href="./references#CD006895-fig-0017" title="">Analysis 1.11</a>) (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>). Two trials were conducted for more than six months, and showed that probiotics were not associated with incidence rate of acute URTIs (rate ratio 1.04, 95% CI 0.63 to 1.71; P = 0.88; 464 participants; <a href="./references#CD006895-fig-0017" title="">Analysis 1.11</a>) (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>).  </p> </section> <section id="CD006895-sec-0088"> <h6 class="title">Comparator</h6> <p>Eleven placebo‐controlled trials showed that probiotics were better than placebo (rate ratio 0.83, 95% CI 0.73 to 0.94; P = 0.003; 4131 participants; <a href="./references#CD006895-fig-0018" title="">Analysis 1.12</a>) (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>), and one trial using no treatment as the comparator did not find an association between probiotics and incidence rate of acute URTIs (rate ratio 0.70, 95% CI 0.47 to 1.04; P = 0.08; 233 participants; <a href="./references#CD006895-fig-0018" title="">Analysis 1.12</a>) (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>). </p> </section> <section id="CD006895-sec-0089"> <h6 class="title">Overall pooled results</h6> <p>Pooled analyses showed that across these trials, probiotics decreased the incidence rate of acute URTIs (rate ratio 0.82, 95% CI 0.73 to 0.92; P = 0.001; 4364 participants; <a href="./references#CD006895-fig-0015" title="">Analysis 1.9</a>; <a href="./references#CD006895-fig-0016" title="">Analysis 1.10</a>; <a href="./references#CD006895-fig-0017" title="">Analysis 1.11</a>; <a href="./references#CD006895-fig-0018" title="">Analysis 1.12</a>). The contour‐enhanced funnel plot for the pooled analysis suggested that some studies with a lower incidence rate of URTIs in the intervention group might be missing (<a href="#CD006895-fig-0006">Figure 6</a>). The level of heterogeneity between these trials was high (Chi<sup>2</sup> = 36.40; df = 11, P = 0.001; I<sup>2</sup> = 70%; <a href="./references#CD006895-fig-0015" title="">Analysis 1.9</a>; <a href="./references#CD006895-fig-0016" title="">Analysis 1.10</a>; <a href="./references#CD006895-fig-0017" title="">Analysis 1.11</a>; <a href="./references#CD006895-fig-0018" title="">Analysis 1.12</a>). We downgraded the certainty of the evidence for this outcome from high to low due to study limitations and publication bias<i>.</i> </p> <div class="figure" id="CD006895-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the incidence rate of acute URTIs." data-id="CD006895-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the incidence rate of acute URTIs. </p> </div> </div> </div> </section> <section id="CD006895-sec-0090"> <h6 class="title">3. Mean duration of an episode of acute URTIs</h6> <p>Six trials reported the mean duration of an episode of acute URTIs (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). There were 1343 participants in the probiotics group and 1063 participants in the placebo or no treatment group.  </p> </section> <section id="CD006895-sec-0091"> <h6 class="title">Age</h6> <p>In five trials conducted in adults, the results showed that the probiotics intervention was better than placebo (MD −1.14, 95% CI −2.15 to −0.13; P = 0.03; 2252 participants; <a href="./references#CD006895-fig-0019" title="">Analysis 1.13</a>) (<a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). One study included older people (the mean age was 83 years old), and showed that probiotics were better than placebo (MD −1.69, 95% CI −2.75 to −0.63; P = 0.002; 154 participants; <a href="./references#CD006895-fig-0019" title="">Analysis 1.13</a>) (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>).  </p> </section> <section id="CD006895-sec-0092"> <h6 class="title">Treatment dose</h6> <p>Four trials used a dose of less than 10<sup>10</sup> CFU/day, and showed that probiotics were not associated with the mean duration of an episode of acute URTIs (MD −0.89, 95% CI −2.09 to 0.31; P = 0.14; 2152 participants; <a href="./references#CD006895-fig-0020" title="">Analysis 1.14</a>) (<a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). Two trials used a dose of more than 10<sup>10</sup> CFU/day, and showed that probiotics were better in reducing the mean duration of an episode of acute URTIs (MD −2.01, 95% CI −2.66 to −1.36; P &lt; 0.001; 254 participants; <a href="./references#CD006895-fig-0020" title="">Analysis 1.14</a>) (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>).  </p> </section> <section id="CD006895-sec-0093"> <h6 class="title">Treatment duration</h6> <p>Four trials were conducted for three to six months, and showed that antibiotics did not affect the mean duration of an episode of acute URTIs (MD −0.90, 95% CI −1.86 to 0.05; P = 0.06; 1773 participants; <a href="./references#CD006895-fig-0021" title="">Analysis 1.15</a>) (<a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>). Two trials were conducted for more than six months, and showed that antibiotics reduce the mean duration of an episode of acute URTIs (MD −1.90, 95% CI −2.04 to −1.76; P &lt; 0.001; 633 participants; <a href="./references#CD006895-fig-0021" title="">Analysis 1.15</a>) (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>).  </p> </section> <section id="CD006895-sec-0094"> <h6 class="title">Overall pooled results</h6> <p>Pooled analyses showed that the MD of an episode of acute URTIs after probiotic treatment decreased (MD −1.22, 95% CI −2.12 to −0.33; P = 0.007; 6 trials, 2406 participants; <a href="./references#CD006895-fig-0019" title="">Analysis 1.13</a>, <a href="./references#CD006895-fig-0020" title="">Analysis 1.14</a>; <a href="./references#CD006895-fig-0021" title="">Analysis 1.15</a>). The level of heterogeneity in terms of the MD of an episode of acute URTIs was high (Chi<sup>2</sup> = 75.60; df = 5, P &lt; 0.001; I<sup>2</sup> = 94%). We downgraded the certainty of the evidence for this outcome from high to low due to study limitations and high heterogeneity. </p> <p>See <a href="./full#CD006895-tbl-0001">summary of findings Table 1</a> for an overall assessment of the primary outcomes. </p> </section> </section> <section id="CD006895-sec-0095"> <h5 class="title">Secondary outcomes</h5> <section id="CD006895-sec-0096"> <h6 class="title">1. Number of participants who were absent from childcare centre, school, or work</h6> <p>One trial reported the number of participants who experienced cold‐related school absence during the follow‐up period (<a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>). This study involved 40 participants in the probiotics group and 40 participants in the placebo group. There were 14 participants in the placebo group who experienced cold‐related absence, whereas there were only two in the probiotics group. The results showed that probiotics decreased the number of participants who were absent from childcare centre, school, or work (RR 0.14, 95% CI 0.03 to 0.59; 1 study, 80 participants; <a href="./references#CD006895-fig-0022" title="">Analysis 2.1</a>). None of the included trials reported time off from childcare centres or work for acute URTIs. We downgraded the certainty of the evidence for this outcome from high to very low due to study limitations, imprecision, and indirectness. </p> </section> <section id="CD006895-sec-0097"> <h6 class="title">2. Number of participants who used antibiotics for acute URTIs</h6> <p>Six trials reported the number of participants who used prescription antibiotics for acute URTIs (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>). One trial was a two‐stage study reporting the number of participants using antibiotics (<a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>). There were 771 participants in the probiotics group and 777 participants in the placebo or no treatment group.  </p> </section> <section id="CD006895-sec-0098"> <h6 class="title">Age</h6> <p>In five trials conducted in children, the results showed that the probiotics intervention was better than placebo or no treatment (RR 0.59, 95% CI 0.43 to 0.83, P = 0.002; 1315 participants; <a href="./references#CD006895-fig-0023" title="">Analysis 3.1</a>) (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>). One study included an adult population, and showed that probiotics did not decrease the number of participants who used prescribed antibiotics for acute URTIs (RR 0.09, 95% CI 0.01 to 1.67; P = 0.11; 233 participants; <a href="./references#CD006895-fig-0023" title="">Analysis 3.1</a>) (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>).  </p> </section> <section id="CD006895-sec-0099"> <h6 class="title">Treatment dose</h6> <p>Four trials used a dose of less than 10<sup>10</sup> CFU/day, and the results showed that the probiotics reduced the number of participants who used prescribed antibiotics for acute URTIs (RR 0.65, 95% CI 0.42 to 0.99; P = 0.05; 1234 participants; <a href="./references#CD006895-fig-0024" title="">Analysis 3.2</a>) (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>). Two trials used a dose of less than 10<sup>10</sup> CFU/day, and showed no difference between probiotics and placebo or no treatment in reducing the number of participants who used prescribed antibiotics for acute URTIs (RR 0.38, 95% CI 0.09 to 1.52; P = 0.17; 314 participants; <a href="./references#CD006895-fig-0024" title="">Analysis 3.2</a>) (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>).  </p> </section> <section id="CD006895-sec-0100"> <h6 class="title">Treatment duration</h6> <p>One trial was conducted for less than three months (<a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>), four trials for three to six months (<a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>), and one trial for more than six months (<a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>). Benefits of probiotics in decreasing in the number of participants who used prescribed antibiotics for acute URTIs were found for the treatment duration more than six months (less than three months: RR 0.68, 95% CI 0.42 to 1.11; P = 0.12; 281 participants; three to six months: RR 0.46, 95% CI 0.20 to 1.10; P = 0.08; 1186 participants; more than six months: RR 0.52, 95% CI 0.31 to 0.88; P = 0.02; 81 participants; <a href="./references#CD006895-fig-0025" title="">Analysis 3.3</a>).  </p> </section> <section id="CD006895-sec-0101"> <h6 class="title">Comparator</h6> <p>Five placebo‐controlled trials showed that probiotic interventions reduced the number of participants who used prescribed antibiotics for acute URTIs (RR 0.59, 95% CI 0.43 to 0.83; P = 0.02; 1315 participants; <a href="./references#CD006895-fig-0026" title="">Analysis 3.4</a>). One trial using no treatment as the comparator did not find an association between the probiotic intervention and the number of participants who used prescribed antibiotics for acute URTIs (<a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>) (RR 0.09, 95% CI 0.01 to 1.67; P = 0.11; 233 participants; <a href="./references#CD006895-fig-0026" title="">Analysis 3.4</a>).  </p> </section> <section id="CD006895-sec-0102"> <h6 class="title">Overall pooled results</h6> <p>Pooled analyses showed that probiotic treatment reduced the number of participants who used prescribed antibiotics for acute URTIs (RR 0.58, 95% CI 0.42 to 0.81; P = 0.001; 1548 participants; <a href="./references#CD006895-fig-0023" title="">Analysis 3.1</a>; <a href="./references#CD006895-fig-0024" title="">Analysis 3.2</a>; <a href="./references#CD006895-fig-0025" title="">Analysis 3.3</a>; <a href="./references#CD006895-fig-0026" title="">Analysis 3.4</a>). We found no heterogeneity (Chi<sup>2</sup> = 3.36; df = 5, P = 0.64; I<sup>2</sup> = 0%; <a href="./references#CD006895-fig-0023" title="">Analysis 3.1</a>; <a href="./references#CD006895-fig-0024" title="">Analysis 3.2</a>; <a href="./references#CD006895-fig-0025" title="">Analysis 3.3</a>; <a href="./references#CD006895-fig-0026" title="">Analysis 3.4</a>). This indicates that the numbers of participants using antibiotics and infections requiring antibiotic prescriptions were lower in the probiotics group than in the placebo or no treatment group. We downgraded the certainty of the evidence for this outcome from high to moderate due to study limitations<i>.</i> </p> </section> <section id="CD006895-sec-0103"> <h6 class="title">3. Number of participants who experienced at least one side effect or adverse event of probiotics </h6> <p>Most of the included trials reported that side effects or adverse events from the intervention were minor. One study described the main adverse effects as gastrointestinal symptoms such as vomiting, flatulence, and increased irritability (<a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>). The probiotics used in the study were <i>Lactobacillus rhamnosus</i> and <i>Bifidobacterium lactis</i> Bb‐12. Eight trials reported side effects including diarrhoea, vomiting, bowel pain, loose stools, flatulence, nausea, etc. (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). There were 1222 participants in the probiotics group and 1234 participants in the placebo or no treatment group.  </p> </section> <section id="CD006895-sec-0104"> <h6 class="title">Age</h6> <p>Three studies included adults (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>), and five trials included children (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). We found no associations between probiotics and the number of participants who experienced at least one side effect or adverse event in either adults (RR 1.03, 95% CI 0.89 to 1.19; P = 0.71; 1414 participants; <a href="./references#CD006895-fig-0027" title="">Analysis 4.1</a>) or children (RR 0.99, 95% CI 0.71 to 1.37; P = 0.93; 1042 participants; <a href="./references#CD006895-fig-0027" title="">Analysis 4.1</a>). </p> </section> <section id="CD006895-sec-0105"> <h6 class="title">Treatment dose</h6> <p>Six trials used a dose of probiotics of less than 10<sup>10</sup> CFU/day (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>), and two trials used a dose of more than 10<sup>10</sup> CFU/day (<a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). We found no associations between probiotics and the number of participants who experienced at least one side effect or adverse event for either the lower dose (RR 1.02, 95% CI 0.90 to 1.16; P = 0.74; 1709 participants; <a href="./references#CD006895-fig-0028" title="">Analysis 4.2</a>) or the higher dose of probiotics (RR 1.46, 95% CI 0.23 to 9.09; P = 0.69; 747 participants; <a href="./references#CD006895-fig-0028" title="">Analysis 4.2</a>). </p> </section> <section id="CD006895-sec-0106"> <h6 class="title">Treatment duration</h6> <p>Six trials were conducted for three to six months (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>), and two trials were conducted for more than six months (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Neither result differed between the probiotics group and the placebo or no treatment group in number of participants who experienced at least one side effect or adverse event of probiotics (three to six months: RR 1.01, 95% CI 0.89 to 1.15; P = 0.88; 2263 participants; more than six months: RR 4.06, 95% CI 0.69 to 23.88; P = 0.12; 193 participants; <a href="./references#CD006895-fig-0029" title="">Analysis 4.3</a>).  </p> </section> <section id="CD006895-sec-0107"> <h6 class="title">Overall pooled results</h6> <p>Pooled analyses showed that there was no difference in side effects between the probiotics group and the placebo or no treatment group (RR 1.02, 95% CI 0.90 to 1.15; P = 0.79; 2456 participants; <a href="./references#CD006895-fig-0027" title="">Analysis 4.1</a>; <a href="./references#CD006895-fig-0028" title="">Analysis 4.2</a>; <a href="./references#CD006895-fig-0029" title="">Analysis 4.3</a>). We found no heterogeneity (Chi<sup>2</sup> = 5.93; df = 7, P = 0.55; I<sup>2</sup> = 0%; <a href="./references#CD006895-fig-0027" title="">Analysis 4.1</a>; <a href="./references#CD006895-fig-0028" title="">Analysis 4.2</a>; <a href="./references#CD006895-fig-0029" title="">Analysis 4.3</a>). We downgraded the certainty of the evidence for this outcome from high to low due to study limitations and imprecision<i>.</i> </p> </section> </section> <section id="CD006895-sec-0108"> <h5 class="title">Sensitivity analysis</h5> <p>We conducted sensitivity analyses by excluding trials at high risk of bias and cluster‐RCTs. The results did not change. </p> </section> </section> <section id="CD006895-sec-0109"> <h4 class="title">Per‐protocol analysis</h4> <p>We also conducted per‐protocol analyses, and these did not change the inference of the original analyses. See <a href="./references#CD006895-fig-0030" title="">Analysis 5.1</a>; <a href="./references#CD006895-fig-0031" title="">Analysis 5.2</a>; <a href="./references#CD006895-fig-0032" title="">Analysis 5.3</a>; <a href="./references#CD006895-fig-0033" title="">Analysis 5.4</a>; <a href="./references#CD006895-fig-0034" title="">Analysis 5.5</a>; <a href="./references#CD006895-fig-0035" title="">Analysis 5.6</a>; <a href="./references#CD006895-fig-0036" title="">Analysis 5.7</a>; <a href="./references#CD006895-fig-0037" title="">Analysis 5.8</a>; <a href="./references#CD006895-fig-0038" title="">Analysis 5.9</a>; <a href="./references#CD006895-fig-0039" title="">Analysis 5.10</a>; <a href="./references#CD006895-fig-0040" title="">Analysis 5.11</a>; <a href="./references#CD006895-fig-0041" title="">Analysis 5.12</a>; <a href="./references#CD006895-fig-0042" title="">Analysis 5.13</a>; <a href="./references#CD006895-fig-0043" title="">Analysis 5.14</a>; <a href="./references#CD006895-fig-0044" title="">Analysis 5.15</a>; <a href="./references#CD006895-fig-0045" title="">Analysis 6.1</a>; <a href="./references#CD006895-fig-0046" title="">Analysis 7.1</a>; <a href="./references#CD006895-fig-0047" title="">Analysis 7.2</a>; <a href="./references#CD006895-fig-0048" title="">Analysis 7.3</a>; <a href="./references#CD006895-fig-0049" title="">Analysis 7.4</a>; <a href="./references#CD006895-fig-0050" title="">Analysis 8.1</a>; <a href="./references#CD006895-fig-0051" title="">Analysis 8.2</a>; <a href="./references#CD006895-fig-0052" title="">Analysis 8.3</a>. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006895-sec-0110" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006895-sec-0110"></div> <section id="CD006895-sec-0111"> <h3 class="title" id="CD006895-sec-0111">Summary of main results</h3> <p>In this review, we found that probiotics may reduce the number of participants who were diagnosed with URTIs (at least one event); likely reduce the number of participants diagnosed with URTIs (at least three events); may reduce the incidence rate of acute URTIs; may reduce the mean duration of an episode of acute URTIs; likely reduce the number of participants who used antibiotics for URTIs; and may not increase the number of participants who experienced at least one adverse event. Adverse events were minor. Evidence showing a decrease in the number of people absent from childcare centre, school, or work due to acute URTIs with probiotics is very uncertain. However, these results must be interpreted with caution because the included outcomes were unsatisfactory and susceptible to bias given that some of them were extracted from only one or two trials, and in some subgroups the level of heterogeneity between pooled trials was substantial. In addition, some trials had small sample sizes and limitations in their methods. Furthermore, the outcomes prespecified as most important in this review were not the main outcomes in some of the original trials. </p> </section> <section id="CD006895-sec-0112"> <h3 class="title" id="CD006895-sec-0112">Overall completeness and applicability of evidence</h3> <section id="CD006895-sec-0113"> <h4 class="title">Probiotics for acute URTIs in children</h4> <p>The majority of the trials included in this review were conducted in children (<a href="./references#CD006895-bbs2-0001" title="AndaloroC , SantagatiM , StefaniS , La MantiaI . Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study. European Archives of Oto-Rhino-Laryngology2019;276(3):879-87. [DOI: 10.1007/s00405-019-05346-3]">Andaloro 2019</a>; <a href="./references#CD006895-bbs2-0004" title="CaceresP , MontesS , VegaN , CruchetS , BrunserO , GottelandM . Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Journal of Pediatric Infectious Diseases2010;5(4):353-62. ">Caceres 2010</a>; <a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0007" title="HojsakI , SnovakN , AbdovicS , SzajewskaH , MisakZ , KolacekS . Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition2010;29(3):312-6. ">Hojsak 2010a</a>; <a href="./references#CD006895-bbs2-0008" title="HojsakI , AbdovicS , SzajewskaH , MilosevicM , KrznaricZ , KolacekS . Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics2010;125(5):e1171-7. ">Hojsak 2010b</a>; <a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0015" title="MerensteinD , MurphyM , FokarA , HernandezRK , ParkH , NsouliH , et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. European Journal of Clinical Nutrition2010;64(7):669-77. ">Merenstein 2010</a>; <a href="./references#CD006895-bbs2-0017" title="RautavaS , SalminenS , IsolauriE . Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2009;101(11):1722-6. ">Rautava 2009</a>; <a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>; <a href="./references#CD006895-bbs2-0019" title="RioME , Zago BeatrizL , GarciaH , WinterL . The nutritional status change the effectiveness of a dietary supplement of lactic bacteria on the emerging of respiratory tract diseases in children [El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños]. Archivos Latinoamericanos de Nutricion2002;52(1):29-34. ">Rio 2002</a>; <a href="./references#CD006895-bbs2-0020" title="SantamariaF , MontellaS , StoccheroM , PirilloP , BozzettoS , GiordanoG , et al. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial. Pulmonary Pharmacology and Therapeutics2019;58:101818. [DOI: 10.1016/j.pupt.2019.101818]">Santamaria 2019</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). We analysed subgroups according to different ages of participants and found that probiotics showed a benefit in reducing the number of children who experienced URTIs episodes (at least one event), the incidence rate of acute URTIs, and the number of participants who used antibiotics for acute URTIs. In most trials the probiotics were given in milk‐based food, such as yoghurt, for three months or more. </p> <p>A double‐blind, placebo‐controlled RCT, conducted in 18 municipal daycare centres in similar socioeconomic areas in north, west, and northeast Helsinki, found that <i>Lactobacillusrhamnosus</i> GG milk may reduce the rate and severity of respiratory infections and antibiotic treatment amongst children in daycare centres (<a href="./references#CD006895-bbs2-0041" title="HatakkaK , SavilahtiE , PonkaA , MeurmanJH , PoussaT , NaseL , et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ2001;322(1298):1327-9. ">Hatakka 2001</a>). One study included 309 otitis‐prone children (with at least four episodes of acute otitis media) (<a href="./references#CD006895-bbs2-0042" title="HatakkaK , BlomgrenK , PohjavuoriS , KaijalainenT , PoussaT , LeinonenM , et al. Treatment of acute otitis media with probiotics in otitis-prone children - a double-blind, placebo-controlled randomised study. Clinical Nutrition2007;26(3):314-21. ">Hatakka 2007</a>). We included <a href="./references#CD006895-bbs2-0042" title="HatakkaK , BlomgrenK , PohjavuoriS , KaijalainenT , PoussaT , LeinonenM , et al. Treatment of acute otitis media with probiotics in otitis-prone children - a double-blind, placebo-controlled randomised study. Clinical Nutrition2007;26(3):314-21. ">Hatakka 2007</a> in the previous version of the review, but after reassessing it in this update, we excluded it because otitis‐prone children may have immunodeficiency. In <a href="./references#CD006895-bbs2-0042" title="HatakkaK , BlomgrenK , PohjavuoriS , KaijalainenT , PoussaT , LeinonenM , et al. Treatment of acute otitis media with probiotics in otitis-prone children - a double-blind, placebo-controlled randomised study. Clinical Nutrition2007;26(3):314-21. ">Hatakka 2007</a>, the trial authors also found that probiotics did not prevent the occurrence of acute otitis media or the nasopharyngeal carriage of otitis pathogens in otitis‐prone children. </p> </section> <section id="CD006895-sec-0114"> <h4 class="title">Probiotics for acute URTIs in adults</h4> <p>Six studies were conducted in adults (<a href="./references#CD006895-bbs2-0002" title="BerggrenA , Lazou AhrenI , LarssonN , OnningG . Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition2011;50(3):203-10. ">Berggren 2011</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>; <a href="./references#CD006895-bbs2-0021" title="ShidaK , SatoT , IizukaR , HoshiR , WatanabeO , IgarashiT , et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. European Journal of Nutrition2017;56(1):45-53. [DOI: 10.1007/s00394-015-1056-1]">Shida 2017</a>; <a href="./references#CD006895-bbs2-0022" title="SmithTJ , Rigassio-RadlerD , DenmarkR , HaleyT , Touger-DeckerR . Effect of Lactobacillus rhamnosus LGGw and Bifidobacterium animalis ssp. lactis BB-12w on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition2013;109(11):1999-2007. ">Smith 2013</a>; <a href="./references#CD006895-bbs2-0024" title="VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clinical Nutrition2005;24(4):481-91. VreseDM , WinklerP , RautenbergP , HarderT , NoahC , LaueC , et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine2006;24(44-6):6670-4. WinklerP , VreseDM , LaueCH , SchrezenmeirJ . Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. International Journal of Clinical Pharmacology and Therapeutics2005;43(7):318-26. ">Vrese 2005</a>). Subgroup analysis showed that probiotics were associated with a reduction in the number of adults who experienced URTIs episodes (only at least one event), the incidence rate of acute URTIs, and the mean duration of an episode of URTIs. However, we did not find that probiotics were beneficial in reducing the number of participants who needed a prescription for antibiotics. In most trials two or three strains of probiotics were given through powder‐like food. </p> </section> <section id="CD006895-sec-0115"> <h4 class="title">Probiotics for acute URTIs in the elderly</h4> <p>Infections often occur in the elderly as the immune system weakens with age (<a href="./references#CD006895-bbs2-0129" title="ValenteSA , Fallon WF Jr, AlexanderTS , TomasER , Evancho-ChapmanMM , SchmidtSP , et al. Immunologic function in the elderly after injury - the neutrophil and innate immunity. Journal of Trauma2009;67:968-74.">Valente 2009</a>). As such, it is very important to compare the treatment effect in older people. To date, we have only found five trials that compared probiotics to placebo in older people (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0039" title="GuillemardE , TonduF , LacoinF , SchrezenmeirJ . Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. British Journal of Nutrition2010;103(1):58-68. ">Guillemard 2010</a>; <a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>; <a href="./references#CD006895-bbs2-0081" title="TurchetP , LaurenzanoM , AuboironS , AntoineJM . Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. Journal of Nutrition, Health and Aging2003;7(2):75-7. ">Turchet 2003</a>). One study was a unicentric, randomised, stratified, open pilot study, in which 360 community residents over 60 years of age were randomised to receive (a) one 100‐millilitre bottle of Actimel (milk fermented with yoghurt cultures and <i>Lactobacillus casei</i> DN‐114 001, containing 10<sup>8</sup> CFU/mL <i>L casei</i> DN‐114 001) twice daily for three weeks, or (b) control (<a href="./references#CD006895-bbs2-0081" title="TurchetP , LaurenzanoM , AuboironS , AntoineJM . Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. Journal of Nutrition, Health and Aging2003;7(2):75-7. ">Turchet 2003</a>). The study found no difference in the incidence of infections during the winter between groups. However, the study authors found that the duration of all pathologies and maximum temperature were lower in the treatment group than in the control group. The other study was also a multicentre, double‐blind controlled trial, involving 1072 participants (median age 76 years) randomised to either probiotic strain <i>L casei</i> DN‐114 001 or placebo for three months (<a href="./references#CD006895-bbs2-0039" title="GuillemardE , TonduF , LacoinF , SchrezenmeirJ . Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. British Journal of Nutrition2010;103(1):58-68. ">Guillemard 2010</a>). The probiotic group was associated with a decreased duration of common infectious diseases in comparison to the placebo, especially URTIs. </p> <p>In our <a href="#CD006895-sec-0016">Criteria for considering studies for this review</a>, we included studies with participants who had been vaccinated against influenza or other acute URTIs within the last 12 months, if the percentage of participants was less than 50%, and there was no difference between groups. Eighty‐two per cent of participants in one study had been vaccinated against influenza three months before the study (<a href="./references#CD006895-bbs2-0081" title="TurchetP , LaurenzanoM , AuboironS , AntoineJM . Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. Journal of Nutrition, Health and Aging2003;7(2):75-7. ">Turchet 2003</a>). In addition, the study did not separate acute URTIs from other infections commonly experienced in winter. Another study included participants who were vaccinated against influenza prior to receiving the intervention (<a href="./references#CD006895-bbs2-0039" title="GuillemardE , TonduF , LacoinF , SchrezenmeirJ . Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. British Journal of Nutrition2010;103(1):58-68. ">Guillemard 2010</a>). We therefore decided to exclude these two studies. </p> <p>One included study contained reports from two trials: the Funagata study and the Arita study (<a href="./references#CD006895-bbs2-0014" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010a</a>). The Arita study was not an RCT, so we excluded <a href="./references#CD006895-bbs2-0063" title="MakinoS , IkegamiS , KumeA , HoriuchiH , SasakiH , OriiN . Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. British Journal of Nutrition2010;104(7):998-1006. ">Makino 2010b</a>. However, the Funagata study had no available data that could be extracted to conduct a meta‐analysis. The study reported that the risk of catching a common cold or influenza was about 3.4 times lower in the probiotic group than in the placebo group. </p> <p>In this 2022 review, we only included two studies considering the effect of probiotics amongst older people (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>). The probiotics were given with milk‐based food or in capsules, for more than six months. The results showed that probiotics did not reduce the incidence rate of acute URTIs, but did reduce the duration of acute URTIs in older people. More trials are needed in elderly populations.  </p> </section> <section id="CD006895-sec-0116"> <h4 class="title">Intervention dose and duration</h4> <p>In this review, we conducted subgroup analyses according to the intervention dose and duration. For the intervention dose, we found that a lower dose of probiotics (less than 10<sup>10</sup> CFU/day) showed a benefit in reducing the number of participants who experienced URTIs episodes (at least one event and at least three events), the incidence rate of acute URTIs, and the number of participants who used antibiotics for acute URTIs, whilst a higher dose of probiotics (more than 10<sup>10</sup> CFU/day) showed a benefit in reducing the number of participants who experienced URTIs episodes (at least one event) and the mean duration of an episode of URTIs. No associations between probiotics and the number of participants who experienced at least one side effect or adverse event were found with either a lower dose (less than 10<sup>10</sup> CFU/day) or a higher dose of probiotics (more than 10<sup>10</sup> CFU/day). Regarding intervention duration, we found that a shorter intervention duration (less than three months) of probiotics was associated with a reduction in the number of participants diagnosed with acute URTIs (at least one event); a moderate intervention duration (three to six months) was associated with a reduction in the number of participants who experienced URTIs episodes (at least one event and at least three events) and the incidence rate of acute URTIs; and a longer intervention duration (more than six months) was associated with a reduction in the mean duration of an episode of URTIs and the number of participants who used antibiotics for acute URTIs. Neither moderate nor longer intervention duration of probiotics was associated with the number of participants who experienced at least one side effect or adverse event. </p> </section> <section id="CD006895-sec-0117"> <h4 class="title">Type of comparator</h4> <p>Two trials used no treatment as the comparison group (<a href="./references#CD006895-bbs2-0009" title="KaraSS , VolkanB , ErtenI . Lactobacillus rhamnosus GG can protect malnourished children. Beneficial Microbes2019;10(3):237-44. [DOI: 10.3920/BM2018.0071]">Kara 2019</a>; <a href="./references#CD006895-bbs2-0016" title="PuF , GuoY , LiM , ZhuH , WangS , ShenX , et al. Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clinical Interventions in Aging2017;12:1223-31. [DOI: 10.2147/CIA.S141518]">Pu 2017</a>). Subgroup analysis according to type of comparator found that probiotics reduced the number of participants who experienced URTIs episodes (both at least one event and at least three events), the incidence rate of acute URTIs, and the number of participants who used antibiotics for acute URTIs in the placebo‐controlled trials, and the number of participants who experienced URTIs episodes (at least one event) in the trials using no treatment group as the control. The results of the placebo‐controlled studies were consistent with the pooled analysis. </p> </section> <section id="CD006895-sec-0118"> <h4 class="title">Clinical interpretation of the data</h4> <p>The analyses showed that probiotics may reduce the number of participants who were diagnosed with URTIs (at least one event); likely reduce the number of participants diagnosed with URTIs (at least three events); may reduce the incidence rate of acute URTIs; may reduce the mean duration of an episode of acute URTIs; likely reduce the number of participants who used antibiotics for URTIs; and may not increase the number of participants who experienced at least one adverse event. Evidence showing a decrease in the number of people absent from childcare centre, school, or work due to acute URTIs with probiotics is very uncertain. The primary outcome of mean duration of an episode of acute URTIs was based on only one or two trials in the elderly and children subgroups. We found only one study that reported school absenteeism due to the common cold; more trials are needed to measure this outcome (<a href="./references#CD006895-bbs2-0018" title="RerksuppapholS , RerksuppapholL . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatrics International2012;54(5):682-7. ">Rerksuppaphol 2012</a>). There were insufficient data for adults and older people in our review. In addition, different ages and settings of participants, types of probiotics, and follow‐up periods were used in the trials, so that heterogeneity in some outcomes could not be avoided. We thus could not conclude a clear intervention dose or duration of probiotics to prevent acute URTIs. Most of trials included in this review used 10<sup>9</sup> or 10<sup>11</sup> CFU/day of probiotics for more than three months, which may indicate that people should take at least 10<sup>9</sup> CFU/day of probiotics for three months to experience these benefits. According to the included trials, probiotics are safe and adverse effects are minor. The major adverse events of probiotics were gastrointestinal symptoms such as diarrhoea, vomiting, flatulence, and increased irritability. The limited results showed that probiotic therapy probably provides more benefits than placebo or no treatment in terms of decreasing the number of participants who were diagnosed with acute URTIs (at least three events) and the number of participants who were prescribed antibiotics for acute URTIs; and may provide more benefits in terms of decreasing the number of participants who were diagnosed with acute URTIs (at least one event), the episodes of infection, and the duration of an episode of acute URTIs. </p> </section> </section> <section id="CD006895-sec-0119"> <h3 class="title" id="CD006895-sec-0119">Certainty of the evidence</h3> <section id="CD006895-sec-0120"> <h4 class="title">Limitations of the included trials</h4> <p>Allocation concealment was only described in seven individual RCTs (<a href="./references#CD006895-bbs2-0005" title="DamholtA , KellerMK , BaranowskiK , BrownB , WichmannA , MelsaetherC , et al. Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial. Beneficial Microbes2022;13(1):13-23. ">Damholt 2022</a>; <a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>; <a href="./references#CD006895-bbs2-0010" title="Langkamp-HenkenB , RoweCC , FordAL , ChristmanMC , Nieves C Jr, KhouriL , et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition2015;113(3):426-34. ">Langkamp‐Henken 2015</a>; <a href="./references#CD006895-bbs2-0011" title="LaursenRP , LarnkjaerA , RitzC , HaugerH , MichaelsenKF , MølgaardC . Probiotics and child care absence due to infections: a randomized controlled trial. Pediatrics2017;140(2):e20170735. [DOI: 10.1542/peds.2017-0735]">Laursen 2017</a>; <a href="./references#CD006895-bbs2-0012" title="Lazou AhrénI , BerggrenA , TeixeiraC , Martinsson NiskanenT , LarssonN . Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. European Journal of Nutrition2020;59(1):409-17. [DOI: 10.1007/s00394-019-02137-8]">Lazou Ahrén 2020</a>; <a href="./references#CD006895-bbs2-0013" title="Lazou AhrénI , HillmanM , NordströmEA , LarssonN , NiskanenTM . Fewer community-acquired colds with daily consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A randomised, placebo-controlled clinical trial. Journal of Nutrition2021;151(1):214-22. [DOI: 10.1093/jn/nxaa353]">Lazou Ahrén 2021</a>; <a href="./references#CD006895-bbs2-0023" title="TaipaleTJ , PienihäkkinenK , IsolauriE , JokelaJT , SöderlingEM . Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research2016;79(1-1):65-9. [DOI: 10.1038/pr.2015.174.]">Taipale 2016</a>). Double‐blinding was reported in 17 trials, and details of the blinding methods were reported in 11 trials. However, four trials did not report the type of blinding, and one trial was unblinded to participants and outcome assessors. All of this could potentially have biased the results in favour of treatment (<a href="#CD006895-fig-0003">Figure 3</a>). </p> <p>After assessment of the overall certainty of the evidence, we downgraded the certainty of the evidence for our primary outcomes from high to moderate or low, usually due to study limitations, inconsistency, imprecision, indirectness, or publication bias. The results of trials were more likely to be positive if the trials were funded by industry or if the authors had a financial conflict of interest. </p> </section> </section> <section id="CD006895-sec-0121"> <h3 class="title" id="CD006895-sec-0121">Potential biases in the review process</h3> <p>We included 24 studies in this 2022 review, 23 of which were used to extract data for meta‐analysis. The limited number of included studies may introduce potential bias. Meanwhile, we excluded some studies that simply reported respiratory tract infection without specifying whether it was lower or upper respiratory tract infection. The effects of probiotics may be underestimated or overestimated, as we may have missed some related studies. However, we attempted to identify all relevant studies, and performed analyses based on both intention‐to‐treat and per‐protocol populations. These would be helpful in reducing potential bias in the review process. </p> </section> <section id="CD006895-sec-0122"> <h3 class="title" id="CD006895-sec-0122">Agreements and disagreements with other studies or reviews</h3> <p>One systematic review was conducted to investigate probiotics supplementation effects on respiratory tract infections in children attending day care (<a href="./references#CD006895-bbs2-0109" title="LaursenRP , HojsakI . Probiotics for respiratory tract infections in children attending day care centers - a systematic review. European Journal of Pediatrics2018;177(7):979-94. [DOI: 10.1007/s00431-018-3167-1]">Laursen 2018</a>). That review suggested low‐certainty evidence for probiotics preventing the number of children with acute URTIs based on five trials. However, <a href="./references#CD006895-bbs2-0109" title="LaursenRP , HojsakI . Probiotics for respiratory tract infections in children attending day care centers - a systematic review. European Journal of Pediatrics2018;177(7):979-94. [DOI: 10.1007/s00431-018-3167-1]">Laursen 2018</a> included another three trials with insufficient information to assess the number of patients with acute URTIs. </p> <p>Another systematic review focused on probiotics supplementation for preventing URTIs amongst adults (<a href="./references#CD006895-bbs2-0112" title="LiL , HongK , SunQ , XiaoH , LaiL , MingM , et al. Probiotics for preventing upper respiratory tract infections in adults: a systematic review and meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine2020;2020:8734140. [DOI: 10.1155/2020/8734140]">Li 2020</a>). The authors included six RCTs and found that probiotics reduce the incidence of URTIs episodes and the mean duration of URTIs compared with placebo. However, the results were based on per‐protocol analysis, which may overestimate the effect of probiotics. </p> <p>We excluded trials performed on athletes, as the excessive training may have influenced the effect of the probiotics or immune system (<a href="./references#CD006895-bbs2-0102" title="GreenhamG , BuckleyJD , GarrettJ , EstonR , NortonK . Biomarkers of physiological responses to periods of intensified, non-resistance-based exercise training in well-trained male athletes: a systematic review and meta-analysis. Sports Medicine2018;48(11):2517-48. [DOI: 10.1007/s40279-018-0969-2]">Greenham 2018</a>). A systematic review was conducted to evaluate probiotics supplementation's effectiveness on athletes' URTIs (<a href="./references#CD006895-bbs2-0132" title="ŁagowskaK , BajerskaJ . Effects of probiotic supplementation on respiratory infection and immune function in athletes: systematic review and meta-analysis of randomized controlled trials. Journal of Athletic Training2021;56(11):1213-23. [DOI: 10.4085/592-20]">Łagowska 2021</a>). The authors found that probiotics supplementation had no effect on the duration of URTIs episodes, but had an effect on total symptom severity score. We also identified one study conducted amongst older people that found that probiotics only reduced the duration of acute URTIs, rather than the number of participants who experienced URTIs episodes (<a href="./references#CD006895-bbs2-0006" title="FujitaR , IimuroS , ShinozakiT , SakamakiK , UemuraY , TakeuchiA , et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. American Journal of Infection Control2013;41(12):1231-5. ">Fujita 2013</a>). Another study found that probiotics did not reduce the rate ratio of episodes of URTIs in older adults (<a href="./references#CD006895-bbs2-0003" title="ButlerCC , LauM , GillespieD , Owen-JonesE , LownM , WoottonM , et al. Effect of probiotic use on antibiotic administration among care home residents: a randomized clinical trial. JAMA2020;324(1):47-56. [DOI: 10.1001/jama.2020.8556]">Butler 2020</a>). We have not found any other systematic reviews that conflict with this review to date. However, there are systematic reviews that focus on critically ill patients. Based on the current evidence, probiotics could not only reduce hospital mortality, but also reduce the incidence of intensive care unit (ICU)‐acquired pneumonia, and were associated with a shorter ICU stay (<a href="./references#CD006895-bbs2-0093" title="BatraP , SoniKD , MathurP . Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials. Journal of Intensive Care2020;15(8):81. [DOI: 10.1186/s40560-020-00487-8]">Batra 2020</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006895-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Chinese Biomedical Literature Database search strategy." data-id="CD006895-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-01.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Chinese Biomedical Literature Database search strategy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-01.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006895-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD006895-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006895-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the number of participants who were diagnosed with acute URTIs: at least 1 event." data-id="CD006895-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-05.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the number of participants who were diagnosed with acute URTIs: at least 1 event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the incidence rate of acute URTIs." data-id="CD006895-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-06.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Contour‐enhanced funnel plot of comparison: intention‐to‐treat analysis: probiotics versus placebo ‐ primary outcome measures, outcome: the incidence rate of acute URTIs. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-FIG-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 1: The number of participants who were diagnosed with acute URTIs: at least 1 event (age)" data-id="CD006895-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 1: The number of participants who were diagnosed with acute URTIs: at least 1 event (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 2: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment dose)" data-id="CD006895-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 2: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 3: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment duration)" data-id="CD006895-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 3: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 4: The number of participants who were diagnosed with acute URTIs: at least 1 event (type of comparator)" data-id="CD006895-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 4: The number of participants who were diagnosed with acute URTIs: at least 1 event (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 5: The number of participants who were diagnosed with acute URTI: at least 3 events (age)" data-id="CD006895-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 5: The number of participants who were diagnosed with acute URTI: at least 3 events (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 6: The number of participants who were diagnosed with acute URTI: at least 3 events (treatment dose)" data-id="CD006895-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 6: The number of participants who were diagnosed with acute URTI: at least 3 events (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 7: The number of participants who were diagnosed with acute URTI: at least 3 events (treatment duration)" data-id="CD006895-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 7: The number of participants who were diagnosed with acute URTI: at least 3 events (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 8: The number of participants who were diagnosed with acute URTI: at least 3 events (type of comparator)" data-id="CD006895-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 8: The number of participants who were diagnosed with acute URTI: at least 3 events (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 9: The incidence rate of acute URTIs (age)" data-id="CD006895-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 9: The incidence rate of acute URTIs (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 10: The incidence rate of acute URTIs (treatment dose)" data-id="CD006895-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 10: The incidence rate of acute URTIs (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 11: The incidence rate of acute URTIs (treatment duration)" data-id="CD006895-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 11: The incidence rate of acute URTIs (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 12: The incidence rate of acute URTIs (type of comparator)" data-id="CD006895-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 12: The incidence rate of acute URTIs (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 13: The mean duration of an episode of acute URTIs (age)" data-id="CD006895-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 13: The mean duration of an episode of acute URTIs (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 14: The mean duration of an episode of acute URTIs (treatment dose)" data-id="CD006895-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 14: The mean duration of an episode of acute URTIs (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 15: The mean duration of an episode of acute URTIs (treatment duration)" data-id="CD006895-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 15: The mean duration of an episode of acute URTIs (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work, Outcome 1: The number of participants who were absent from childcare centre, school, or work due to acute URTIs" data-id="CD006895-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work, Outcome 1: The number of participants who were absent from childcare centre, school, or work due to acute URTIs </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 1: The number of participants who used antibiotics for acute URTIs (age)" data-id="CD006895-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 1: The number of participants who used antibiotics for acute URTIs (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 2: The number of participants who used antibiotics for acute URTIs (treatment dose)" data-id="CD006895-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 2: The number of participants who used antibiotics for acute URTIs (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 3: The number of participants who used antibiotics for acute URTIs (treatment duration)" data-id="CD006895-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 3: The number of participants who used antibiotics for acute URTIs (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 4: The number of participants who used antibiotics for acute URTIs (type of comparator)" data-id="CD006895-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 4: The number of participants who used antibiotics for acute URTIs (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 1: The number of participants who experienced at least 1 adverse event (age)" data-id="CD006895-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 1: The number of participants who experienced at least 1 adverse event (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 2: The number of participants who experienced at least 1 adverse event (treatment dose)" data-id="CD006895-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 2: The number of participants who experienced at least 1 adverse event (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 3: The number of participants who experienced at least 1 adverse event (treatment duration)" data-id="CD006895-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 3: The number of participants who experienced at least 1 adverse event (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 1: The number of participants who were diagnosed with acute URTIs: at least 1 event (age)" data-id="CD006895-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 1: The number of participants who were diagnosed with acute URTIs: at least 1 event (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 2: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment dose)" data-id="CD006895-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 2: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 3: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment duration)" data-id="CD006895-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 3: The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 4: The number of participants who were diagnosed with acute URTIs: at least 1 event (type of comparator)" data-id="CD006895-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 4: The number of participants who were diagnosed with acute URTIs: at least 1 event (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 5: The number of participants who were diagnosed with acute URTIs: at least 3 events (age)" data-id="CD006895-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 5: The number of participants who were diagnosed with acute URTIs: at least 3 events (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 6: The number of participants who were diagnosed with acute URTIs: at least 3 events (treatment dose)" data-id="CD006895-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 6: The number of participants who were diagnosed with acute URTIs: at least 3 events (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 7: The number of participants who were diagnosed with acute URTIs: at least 3 events (treatment duration)" data-id="CD006895-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 7: The number of participants who were diagnosed with acute URTIs: at least 3 events (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 8: The number of participants who were diagnosed with acute URTIs: at least 3 events (type of comparator)" data-id="CD006895-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 8: The number of participants who were diagnosed with acute URTIs: at least 3 events (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 9: The incidence rate of acute URTIs (age)" data-id="CD006895-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 9: The incidence rate of acute URTIs (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 10: The incidence rate of acute URTIs (treatment dose)" data-id="CD006895-fig-0039" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 10: The incidence rate of acute URTIs (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 11: The incidence rate of acute URTIs (treatment duration)" data-id="CD006895-fig-0040" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 11: The incidence rate of acute URTIs (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 12: The incidence rate of acute URTIs (type of comparator)" data-id="CD006895-fig-0041" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 12: The incidence rate of acute URTIs (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 13: The mean duration of an episode of acute URTIs (age)" data-id="CD006895-fig-0042" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 13: The mean duration of an episode of acute URTIs (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 14: The mean duration of an episode of acute URTIs (treatment dose)" data-id="CD006895-fig-0043" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 14: The mean duration of an episode of acute URTIs (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-005.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 15: The mean duration of an episode of acute URTIs (treatment duration)" data-id="CD006895-fig-0044" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-005.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.15</div> <div class="figure-caption"> <p>Comparison 5: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures, Outcome 15: The mean duration of an episode of acute URTIs (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-005.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work, Outcome 1: The number of participants who experienced time off from childcare centre, school, or work due to acute URTIs" data-id="CD006895-fig-0045" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work, Outcome 1: The number of participants who experienced time off from childcare centre, school, or work due to acute URTIs </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 1: The number of participants who used antibiotics for acute URTIs (age)" data-id="CD006895-fig-0046" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 1: The number of participants who used antibiotics for acute URTIs (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 2: The number of participants who used antibiotics for acute URTIs (treatment dose)" data-id="CD006895-fig-0047" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 2: The number of participants who used antibiotics for acute URTIs (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 3: The number of participants who used antibiotics for acute URTIs (treatment duration)" data-id="CD006895-fig-0048" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 3: The number of participants who used antibiotics for acute URTIs (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 4: The number of participants who used antibiotics for acute URTIs (type of comparator)" data-id="CD006895-fig-0049" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs, Outcome 4: The number of participants who used antibiotics for acute URTIs (type of comparator) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 1: The number of participants who experienced at least 1 adverse event (age)" data-id="CD006895-fig-0050" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 1: The number of participants who experienced at least 1 adverse event (age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 2: The number of participants who experienced at least 1 adverse event (treatment dose)" data-id="CD006895-fig-0051" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 2: The number of participants who experienced at least 1 adverse event (treatment dose) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006895-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/urn:x-wiley:14651858:media:CD006895:CD006895-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 3: The number of participants who experienced at least 1 adverse event (treatment duration)" data-id="CD006895-fig-0052" src="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_t/tCD006895-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events, Outcome 3: The number of participants who experienced at least 1 adverse event (treatment duration) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/media/CDSR/CD006895/image_n/nCD006895-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006895-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics compared to placebo or no treatment for preventing acute upper respiratory tract infections</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Intention‐to‐treat analysis: probiotics compared to placebo or no treatment for preventing acute upper respiratory tract infections</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children, adults, and the elderly </p> <p><b>Setting:</b> in the community, care facilities, school, or hospital </p> <p><b>Intervention:</b> probiotics </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo or no treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with probiotics</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who were diagnosed with acute URTIs: at least 1 event</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.76<br/>(0.67 to 0.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4798<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>447 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>340 per 1000<br/>(300 to 389) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who were diagnosed with acute URTIs: at least 3 events</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.38 to 0.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>763<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>76 per 1000<br/>(49 to 117) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incidence rate of acute URTIs</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rate ratio 0.82<br/>(0.73 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4364<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean duration of an episode of acute URTIs</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of an episode of URTIs in the probiotics group was 1.22 days lower<br/>(2.12 to 0.33 lower). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2406<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who were absent from childcare centre, school, or work due to acute URTIs </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.14<br/>(0.03 to 0.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d,e,f</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/>(1 to 21) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who used prescribed antibiotics for acute URTIs</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/>(0.42 to 0.81) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1548<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000<br/>(42 to 81) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of participants who experienced at least 1 side effect or adverse event</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.02<br/>(0.90 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2456<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,g</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>233 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>238 per 1000 (210 to 268)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>URTI:</b> upper respiratory tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once for study limitations, as most information was from studies at unclear risk of bias.<br/><sup>b</sup>Downgraded once for publication bias, as the funnel plot was asymmetrical.<br/><sup>c</sup>Downgraded once for inconsistency due to the higher I<sup>2</sup> statistic (93%).<br/><sup>d</sup>Downgraded once for study limitations due to unclear risk of bias for allocation concealment and selective reporting.<br/><sup>e</sup>Downgraded once for imprecision due to the wide 95% CI.<br/><sup>f</sup>Downgraded once for indirectness, as the included study only reported school absenteeism due to the common cold.<br/><sup>g</sup>Downgraded once for imprecision, as the CI overlapped no effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics compared to placebo or no treatment for preventing acute upper respiratory tract infections</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/full#CD006895-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 The number of participants who were diagnosed with acute URTIs: at least 1 event (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.67, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.65, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.58, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Elderly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.68, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.67, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.67, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>677</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.50, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.67, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Less than 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.50, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3704</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.71, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.53, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 The number of participants who were diagnosed with acute URTIs: at least 1 event (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.67, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.68, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.49, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 The number of participants who were diagnosed with acute URTI: at least 3 events (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>763</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.38, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.20, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.36, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 The number of participants who were diagnosed with acute URTI: at least 3 events (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>763</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.38, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.36, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.20, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 The number of participants who were diagnosed with acute URTI: at least 3 events (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>763</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.38, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>682</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.38, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.20, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 The number of participants who were diagnosed with acute URTI: at least 3 events (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>763</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.38, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>530</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.37, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.08 [0.13, 74.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 The incidence rate of acute URTIs (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2032</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.71, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.65, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.3 Elderly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.63, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 The incidence rate of acute URTIs (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.65, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.75, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 The incidence rate of acute URTIs (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3900</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.70, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.63, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 The incidence rate of acute URTIs (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.73, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.47, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 The mean duration of an episode of acute URTIs (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐2.12, ‐0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.14 [‐2.15, ‐0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 Elderly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.69 [‐2.75, ‐0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 The mean duration of an episode of acute URTIs (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐2.12, ‐0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.89 [‐2.09, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.01 [‐2.66, ‐1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 The mean duration of an episode of acute URTIs (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐2.12, ‐0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1773</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐1.86, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>633</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐2.04, ‐1.76]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ primary outcome measures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 The number of participants who were absent from childcare centre, school, or work due to acute URTIs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 The number of participants who used antibiotics for acute URTIs (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.42, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.43, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 The number of participants who used antibiotics for acute URTIs (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.42, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.42, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.09, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 The number of participants who used antibiotics for acute URTIs (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.42, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Less than 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.42, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.20, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.3 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.31, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 The number of participants who used antibiotics for acute URTIs (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.42, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.43, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.67]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 The number of participants who experienced at least 1 adverse event (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.90, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.89, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.71, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 The number of participants who experienced at least 1 adverse event (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.90, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.90, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>747</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.23, 9.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 The number of participants who experienced at least 1 adverse event (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.90, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.89, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.06 [0.69, 23.88]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Intention‐to‐treat analysis: probiotics versus placebo or no treatment ‐ adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 The number of participants who were diagnosed with acute URTIs: at least 1 event (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.67, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.65, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.60, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.3 Elderly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.66, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.67, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.68, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>574</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.51, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 The number of participants who were diagnosed with acute URTIs: at least 1 event (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.67, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 Less than 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.49, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.2 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.72, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.3 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>615</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.54, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 The number of participants who were diagnosed with acute URTIs: at least 1 event (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.67, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.69, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.47, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 The number of participants who were diagnosed with acute URTIs: at least 3 events (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.36, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.20, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.33, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 The number of participants who were diagnosed with acute URTIs: at least 3 events (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.36, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.34, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.19, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.7 The number of participants who were diagnosed with acute URTIs: at least 3 events (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.36, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.35, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.17, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.8 The number of participants who were diagnosed with acute URTIs: at least 3 events (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.36, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.35, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.97 [0.12, 72.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.9 The incidence rate of acute URTIs (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1927</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.70, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.66, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.3 Elderly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.63, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.10 The incidence rate of acute URTIs (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.64, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.75, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.11 The incidence rate of acute URTIs (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.11.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.71, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.11.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.63, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.12 The incidence rate of acute URTIs (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.12.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.12.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.46, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.13 The mean duration of an episode of acute URTIs (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐2.12, ‐0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.13.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.14 [‐2.16, ‐0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.13.2 Elderly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.69 [‐2.83, ‐0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.14 The mean duration of an episode of acute URTIs (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐2.12, ‐0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.14.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.89 [‐2.09, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.14.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.02 [‐2.70, ‐1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.15 The mean duration of an episode of acute URTIs (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐2.12, ‐0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.15.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.89 [‐1.85, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.15.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>588</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐2.04, ‐1.75]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ primary outcome measures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 The number of participants who experienced time off from childcare centre, school, or work due to acute URTIs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ time off from childcare centre, school, or work</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 The number of participants who used antibiotics for acute URTIs (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.40, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.41, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 The number of participants who used antibiotics for acute URTIs (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.40, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.40, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.17, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 The number of participants who used antibiotics for acute URTIs (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.40, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.1 Less than 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.40, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.2 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1094</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.18, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.3 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.29, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 The number of participants who used antibiotics for acute URTIs (type of comparator) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.40, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.1 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.41, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.2 No treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 2.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ prescribed antibiotics for acute URTIs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006895-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 The number of participants who experienced at least 1 adverse event (age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.89, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.89, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>888</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.71, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 The number of participants who experienced at least 1 adverse event (treatment dose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.89, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 Less than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1578</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.89, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.2 More than 1010 CFU per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.31, 4.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 The number of participants who experienced at least 1 adverse event (treatment duration) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.89, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.1 3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.88, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.2 More than 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.71 [0.62, 22.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Per‐protocol analysis: probiotics versus placebo or no treatment ‐ adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006895.pub4/references#CD006895-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006895.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006895-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006895-note-0015">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006895-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006895-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD006895-note-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="hu#CD006895-note-0014">Magyar</a> </li> <li class="section-language"> <a class="" href="ja#CD006895-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD006895-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD006895-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD006895-note-0007">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006895-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006895\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006895\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006895\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006895\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006895\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006895.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006895.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006895.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006895.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006895.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725896099"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006895.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725896103"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006895.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e8669a8529371',t:'MTc0MDcyNTg5Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 